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Prologue
In May 2013, during my last internship at a geronto-psychiatric hospital and two months 
away from taking Hippocrates’ oath to become a medical doctor, patient A, a seventy-
three-year-old male, was admitted to our ward. He has exhibited ‘strange behaviour’ for 
almost two years, and has had no medical record to date. His behaviour consisted of being 
passive to the point of being completely unable to take care of himself, and he showed 
no initiative towards washing or feeding himself. At home, he had passed his days by 
sitting at his kitchen table while tapping his feet and making nonsensical sounds. Further 
spontaneous movement was absent. At the ward, he felt depressed because he worried 
whether he would ever be able to go home again – a realistic worry considering his state. 
Extended physical examination, including blood analysis and imaging of the brain, did 
not show any abnormalities. Neurocognitive tests showed attention and memory deficits, 
which could be caused by either a depression or a neurocognitive disorder. Several 
antipsychotics and antidepressants were tried, to no avail. 
A major depressive disorder was diagnosed, based on his depressed feelings, diminished 
enjoyment in his usual activities, and pessimistic thoughts. At the ward, both the repetitive 
movements and the lack of spontaneous movements were classified as symptoms of 
catatonia, which clouded his other depressive symptoms and complicated diagnosis. He 
was treated with electroconvulsive therapy (ECT). During the treatment, he began talking 
more frequently, telling the doctors he has felt completely emotionally empty during the 
past year and a half. After sixteen sessions of ECT, his depression was in full remission, 
and after a few more months he was discharged from the ward, to his own home. 
Neurocognitive tests showed no abnormalities anymore, in spite of the ECT course which 
often causes (transient) memory deficits as a side effect. At the same time my training 
ended and I started working elsewhere – but a few years later, I coincidentally met him at 
the shop where he used to volunteer before his depression took over. He told me he had 
resumed his volunteer work after being dismissed from our hospital; his depression had 
been in remission ever since. 
During the same period, patient B, a sixty-nine-year-old female, was admitted to the 
ward for ECT. She was diagnosed with a major depressive disorder two years ago, but 
antidepressant treatment had been ineffective, despite trying numerous kinds of 
antidepressants. She felt depressed, although her mood improved a little when she was 
around other people. Her appetite has increased and she has gained weight over the 
course of her depression. She slept around twelve hours each day, and has a hard time 
getting out of bed. She had trouble concentrating, as well as pessimistic thoughts, and the 
lack of improvement, despite trying numerous antidepressants and psychotherapy, had 
left her increasingly hopeless about her future. She had recurrent suicidal thoughts, but 
still hoped ECT can improve her situation. Neurocognitive tests showed no abnormalities. 
She was treated in accordance with the Dutch ECT-protocol, and received six unilateral 
treatments. When she did not improve at all, treatment was switched to bilateral, again 
with no improvement. After twelve sessions with adequate seizures, the medical staff 
concluded that continuing was not useful, and in agreement with the patient and 
according to Dutch guidelines, the ECT was discontinued. A monoamine oxidase inhibitor 
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(MAOI) was then started, which was the one type of antidepressant she had not tried yet. 
After a few weeks, she felt remarkably better. She told me she felt less depressed, was 
making plans for the day, had adopted a healthier diet, and felt less tired all day. After 
another three weeks, her depression was in remission, and she was discharged from the 
ward. 
These cases illustrate the heterogeneity in clinical presentations and treatment response 
of major depressive disorder in later life. Both patients had the same diagnosis of major 
depressive disorder, although their symptoms varied greatly. In fact, with the current 
criteria in the Diagnostic and Statistic Manual for Mental Disorders, fifth edition (DSM-
5) (American Psychiatry Association, 2013), there are 227 possible ways to meet the 
symptom criteria for major depressive disorder (Zimmerman et al. 2015). Ultimately both 
of our patients had a very good response to treatment, but both also faced a great delay 
in finding effective treatment, with the time from onset of the index episode to remission 
being around a year and a half. Both were treated in accordance with the Dutch depression 
protocols, but these standard protocols do not take different symptoms patterns into 
account. Researchers have been trying to address this heterogeneity in treatment 
response for a long time now, but the currently used, DSM-based depression subtypes 
do not correlate with specific forms of treatment. However, improving our knowledge 
on late-life depression is of paramount importance, since late-life depression places a 
high burden on both the patient (Gallo et al. 2007), caregivers (Scazufca et al. 2002) and 
society (Hughes et al. 1997), and has a worse prognosis than depression in younger adults 
(Schaakxs et al. 2018). 
Recognizing that depression is a heterogeneous concept, with different subtypes 
requiring different forms of treatment, is not new. For instance, the DSM-5 acknowledges 
‘melancholic depression’ as a subtype, a concept which traces back to the early 1900’s 
when Kraepelin coined a similar concept (Taylor and Fink 2006). The word itself is even 
older; in ancient Greece, µέλαινα χολή or melaina cholè means black bile, one of the 
four humours or bodily fluids and thought to be excessively present in persons with a 
melancholic temperament. According to Hippocrates, an abundance of black bile leads 
to an immense sadness, despair, and an inability to feel and to love (Hippocrates, 400 BC). 
Over the centuries, however, melancholy became less of a disease characterised by too 
much black bile and more of a Romantic, fashionable sense of suffering. It was thought 
a melancholic temperament increased sensitivity and fantasy, with artists pursuing this 
state as it would enable them to truly rise above themselves (Strong 1969). But in the 
late 19th century the German psychiatrist Emil Kraepelin, often referred to as the founding 
father of modern psychiatry, reframed melancholy as a severe mood disorder, which 
took psychotic and stuporous features into regard. Elaborating on the work of Kraepelin, 
Hopewell - Ash characterised melancholia in 1934 as a depressed state with depression 
of spirits, psychomotor retardation and general torpidity, with additional insomnia, 
constipation, morbid and restless anxiety, but at the same time a general slowing of the 
rhythm (Taylor and Fink 2006).
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Currently, the DSM-5 recognizes melancholia as subtype of depression, among several 
other subtypes, including: ‘with melancholic features’, ‘with atypical features’, ‘with 
psychotic symptoms’, ‘with catatonia’, ‘with a postpartum onset’, and ‘seasonally bound 
depression’ (American Psychiatry Association 2013). These subtypes, however, are as 
heterogeneous as the original concept of depression itself. Melancholic and atypical 
depression says something about the quality or profile of a set of symptoms, while psychotic 
and catatonic symptoms are additional features that could well coexist with either a 
melancholic or atypical depression. The subtype ‘with a postpartum onset’ only describes 
the moment in life someone develops a first depressive episode, while seasonally bound 
depression has the cyclic nature of the depression as main distinguishing characteristic. 
These latter two subtypes do not provide information on the nature of the symptoms, 
either. Therefore, it could be possible that someone develops a first depressive episode 
postpartum, which goes on to have a season bound recurrence, with both melancholic 
and psychotic symptoms. Even more complicated, in later life depression is often thought 
to have a different presentation, with more somatic symptoms. Furthermore, atypical 
symptoms like weight gain could be nullified by muscle weight loss due to frailty and 
comorbidity. It is therefore not hard to imagine that this overlap between subtypes and 
symptoms makes it difficult for researchers to identify a subtype for research. 
Part I: depressive subtypes and the NESDO study
Several studies have set out to improve the current subtypes, aiming to improve our 
understanding of depression and predictive value of subtypes on treatment and 
prognosis. The two main methods of subtyping that are used are either clinically based 
or data driven. With clinically defined subtypes, already existing criteria of subtypes, for 
instance DSM-derived atypical or melancholic subtypes, are used to characterize patients 
and examine their response to different treatments. Data-driven methods on the other 
hand, are trying to subtype patients without pre-existing hypotheses. These techniques 
cluster patients based on their congregate of different depressive symptoms.
In depressed younger adults, studies using latent class analysis (a specific data-driven 
method) have identified subtypes closely resembling (but not entirely matching) the 
DSM-based melancholic and atypical subtypes (Lamers et al. 2010; Alexandrino – Silva et 
al. 2013; Rodgers et al. 2013). This melancholic subtype was characterised by a decrease in 
appetite, weight and sleep, whereas the atypical subtype was driven by a gain in appetite, 
weight and sleep. Furthermore, the melancholic subtype had a higher prevalence of 
cortisol disturbances compared to non-melancholic subjects (Lamers et al. 2013; Penninx 
et al. 2013), while the atypical subtype showed higher serum inflammation parameters. 
Genetic examination also revealed a different genetic profile for the atypical subtype, with 
persons of the atypical subtype having a higher prevalence of genes linked to metabolic 
syndrome (Milaneschi et al. 2016). As could be predicted from aforementioned biological 
and genetic findings, the atypical subtype also proved to be the most stable over time, 
with a stability varying from 71 to 79% (Lamers et al. 2012; Rodgers et al. 2014). 
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In older depressed adults, latent class analyses have also been performed. However, since 
no study differentiated between increase and decrease in appetite, weight, and sleep, 
their resulting subtypes were not comparable to those found in the aforementioned 
studies in younger adults. Studies on inflammatory parameters and cortisol measures in 
older depressed adults often do not take subtypes of depression into account, and show 
inconsistent findings regarding both cortisol (Belvederi Murri et al. 2014) and inflammation 
(Martinez-Cengotitabengoa et al. 2016). Since studies in younger depressed adults show 
that these disturbances seem to be specifically tied to subtypes, we think that the lack of 
consistent outcomes on biological disturbances in late-life depression relied on the lack 
of taking the heterogeneity of depression into account. 
A potentially very useful study to answer questions on the nature of late-life depression is 
the Netherlands Study on Depression in Old Age (NESDO) (Comijs et al. 2011). This study 
included 510 depressed and non-depressed persons sixty years or older, from 2007 until 
2010. Patients were recruited from five cities throughout the Netherlands (Amsterdam, 
Apeldoorn/ Zutphen, Groningen, Leiden, and Nijmegen), from both mental health care 
institutes and general practices. Healthy controls were recruited through general practices. 
At baseline, depression was measured through items of the Composite International 
Diagnostic Interview (CIDI) and defined in line with the DSM-IV criteria (American 
Psychiatry Association 2000). Somatic and psychiatric comorbidity was measured through 
several questionnaires and interviews. Demographic, psychosocial, biological, cognitive 
and genetic determinants were collected. Participants underwent a medical examination, 
and blood and saliva samples were collected. The baseline NESDO sample consisted of 
378 depressed persons and 132 non-depressed persons. Age ranged from 60-93 years old; 
for the depressed persons their mean age of depression onset was 49 years. Follow-up 
assessments were made every six months with written questionnaires, and face-to-face 
follow-up assessments occurred at two years and six years post baseline.
The aim of the first part of this thesis are to examine whether we can determine meaningful 
subtypes in late-life depression using data-driven approaches. We hypothesize that 
possible subtypes found will also have different demographics and clinical profiles, and 
that biological disturbances in late-life depression are subtype dependent. 
For the study in chapter 2, ‘Depressive subtypes in an elderly cohort identified using 
latent class analysis’, we did a latent class analysis including the depressed persons with 
no missing data on baseline depressive symptoms (N=359). Although latent class analyses 
have been performed before on older depressed persons (Hybels et al. 2009; Lee et al. 
2012; Mezuk and Kendler 2012), we divided the items appetite, weight change, sleep, 
and psychomotor symptoms in either gain or loss, an approach which differed to the 
aforementioned studies. Studies in younger adults have already showed the importance 
of this difference in determining subtypes; in our study, we wanted to examine whether 
this is the case for older adults, too. 
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Chapter 3, ‘Inflammatory markers and cortisol parameters across depressive subtypes in 
an older cohort’, examined differences in inflammation parameters and cortisol measures 
across our previously identified subtypes. Since in younger adults an increase in these 
biological parameters was tied to respective subtypes, we hypothesised that the lack of 
homogeneous results in the older population was due to the heterogeneity of late-life 
depression. Taking subtypes of depression into account would respect this heterogeneity, 
and could help determine the pathophysiological mechanisms of late-life depression in 
different subtypes.
Our fourth chapter, titled ‘Stability and transition of depressive subtypes in older 
adults’, examined whether our earlier detected subtypes are stable over time, thereby 
determining their clinical relevance. We did this by performing a latent transition analysis 
(LTA). This analysis consisted of two separate latent class analyses on the same cohort, on 
two different points in time ( baseline (T0) and two year follow-up (T1)). The found classes 
are then compared, and the stability of classes is being examined.
Part II: Depression subtypes and ECT outcome. Findings from the MODECT 
study
In clinical practice, it is common knowledge that particularly melancholic depression 
benefits from ECT, although findings from clinical studies are inconsistent. A possible 
explanation is that a DSM diagnosis of melancholia does not require psychomotor 
disturbances (American Psychiatry Association 2013), even though psychomotor 
symptoms are thought to be a core characteristic of melancholic depression and have 
also been identified as predictor of response to ECT (Fink et al. 2007). ECT, among other 
effects, strongly enhances dopamine, the neurotransmitter mainly responsible for motor 
and psychomotor functioning (Nutt 2006). We hypothesized that a positive outcome of 
ECT on depression could be better predicted by focusing on psychomotor disturbances 
rather than the DSM diagnosis of melancholia. The CORE is a questionnaire measuring 
both psychomotor retardation and agitation, and in an earlier study in younger adults 
higher CORE scores predicted ECT response (Parker and Hadzi-Pavlovic 1996; Hickie et al. 
1996). However, research on older adults is limited.
In addition to the efficacy of ECT on patients with specific symptoms, it is unknown 
whether all symptoms of depression benefit equally from ECT. Earlier studies on 
antidepressants found that not all depressive symptoms resolve with the same speed, 
and that remission often takes weeks to months (Bhar et al. 2008). On the other hand, ECT 
is known to rapidly ameliorate depressive symptoms, especially in older adults (Spaans 
et al. 2016), and especially psychomotor symptoms (Parker et al. 2010). However, further 
insight into the course trajectories of depressive symptoms within older persons treated 
with ECT is lacking.
In order to examine the efficacy of ECT on different symptoms of depression, data was 
derived from the Mood Disorders in Elderly treated with Electro Convulsive Therapy 
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(MODECT) study (Dols et al. 2017). This is a two-site naturalistic, longitudinal study 
including older in-patients (55 years or older) with severe unipolar depression according to 
DSM-IV-TR criteria (American Psychiatric Association (APA), 2013), referred for ECT (N=118). 
Patients were recruited from tertiary psychiatric hospitals (GGZ inGeest, Amsterdam, the 
Netherlands and University Psychiatric Center, KU Leuven, Belgium). Exclusion criteria 
were a DSM-IV-TR diagnoses of bipolar disorder and schizoaffective disorder and a history 
of major neurologic illness. The diagnoses were made by a psychiatrist and confirmed by 
the Mini International Neuropsychiatric Interview (Sheehan et al. 1998). Primary indication 
for ECT included pharmacotherapy resistance as assessed with the Antidepressant 
Treatment History Form (Prudic et al. 1996), life-threatening symptoms, elective, or other. 
Demographic and clinical variables were obtained by interview and double-checked by 
chart review. Physical comorbidity and medication use were assessed in a semistructured 
interview. During ECT, the Montgomery Asberg Depression Rating Scale (MADRS) 
(Folstein et al. 1975) was used to evaluate the depressive symptom severity during the 
treatment course. Cognitive functioning before, during and after the treatment course 
was measured by the Mini Mental State Exam (MMSE) (Hartong and Goedkoop, 1985).
The aims of the second part of this thesis are to examine whether ECT response could be 
predicted by the presence of psychomotor disturbances, with respect to both the number 
of patients reaching remission and the speed of their recovery. To test whether ECT 
improves all symptoms of depression, we examined the response of different depressive 
symptoms to ECT, as well as the speed of response.
In chapter 5, ‘Differences in characteristics and ECT outcome between melancholic 
and non-melancholic depressed older patients’, we examined whether psychomotor 
disturbances, as measured by the CORE, were a predictor of ECT outcome. We included 
patients from the MODECT study. Characteristics were compared across melancholic and 
non-melancholic patients. Furthermore the relation between psychomotor symptoms 
and remission/response, and their difference in time, was examined.
Chapter 6, ‘Differences in speed of response of depressive symptom dimensions in older 
persons during Electro Convulsive Therapy’, focuses on the question of whether ECT 
relieves all symptoms of depression, and whether each of the symptoms improve at the 
same speed. Both pharmacotherapy and psychotherapy do not relieve all depressive 
symptoms or symptom clusters, or not at the same speed. If all symptoms of depression 
will improve swiftly under ECT, this would be another argument to consider ECT as one 
of the first treatment options in late-life depression. Exploratory factor analysis was 
used to identify symptom dimensions, using the ten depression items of the MADRS. 
Thereafter, differences in course trajectories of symptom dimensions during two weeks 
were examined by multilevel analyses.
Chapter 7 of this thesis summarizes and discusses its main findings. This chapter provides 
a critical appraisal of subtypes of late-life depression, their stability over time and their 
response to treatment. Furthermore, methodological considerations will be given and 
strengths and limitations will be discussed. Finally, some clinical implications and future 
directions for clinical research will be described.
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Background: Clinical findings indicate heterogeneity of depressive disorders, stressing the 
importance of subtyping depression for research and clinical care. Subtypes of the common late life 
depression are however seldom studied. Data-driven methods may help provide a more empirically-
based classification of late-life depression.
Methods: Data were used from the Netherlands Study of Depression in Older People (NESDO) 
derived from 359 persons, aged 60 years or older, with a current diagnosis of major depressive 
disorder. Latent class analysis (LCA) was used to identify subtypes of depression, using ten CIDI-
based depression items. Classes were then characterized using various sociodemographic and 
clinical characteristics.
Results: The most prevalent class, as identified by LCA, was a moderate-severe class (prevalence 
46.5%), followed by a severe melancholic class (prevalence 38.4%), and a severe atypical class 
(prevalence 15.0%). The strongest distinguishing features between the three classes were appetite 
and weight and, to a lesser extent, psychomotor symptoms and loss of interest. Compared with 
the melancholic class, the severe atypical class had the highest prevalence of females, the lowest 
mean age, the highest BMI, and highest prevalence of both cardiovascular disease, and metabolic 
syndrome. 
Limitations: The strongest distinguishing symptoms, appetite and weight, could be correlated. 
Further, only longitudinal studies could demonstrate whether the identified classes are stable on 
the long term.
Discussion: In older persons with depressive disorders, three distinct subtypes were identified, 
similar to subtypes found in younger adults. The strongest distinguishing features were appetite and 
weight; moreover, classes differed strongly on prevalence of metabolic syndrome and cardiovascular 
disease. These findings suggest differences in the involvement of metabolic pathways across classes, 
which should be considered when investigating the pathogenesis and (eventually) treatment of 
depression in older persons.
Key words: latent class analysis, depression subtypes, atypical depression, melancholic depression, 
metabolic syndrome
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Background
Late-life depression is a very common disorder. In older persons living in different settings 
(e.g. from private households to institutions) prevalence rates of major depressive 
disorder (MDD) are estimated at 1-16% (Djernes 2006). In addition, depressive disorders 
among older persons are frequently of a chronic nature, with a high burden for both 
patients (Gallo et al., 2007) and their caregivers (Scazufca et al., 2002) and with high 
societal costs (Hughes et al., 1997; Unützer et al., 2009). Insight into the pathogenesis 
and possible treatment options is therefore of paramount importance. However, research 
on the aetiology and pathogenesis is impeded by the heterogeneity of depression and 
differences in biological underpinnings across subtypes, as demonstrated in younger 
adults (Marijnissen et al., 2011; Lamers et al., 2013; Liu et al., 2014; Vogelzangs et al., 2014; 
Mansur et al., 2015; Milaneschi et al., 2016). 
Data-driven techniques are a fruitful way to investigate heterogeneity in depressive 
disorders (Lubke and Muthén 2005). These techniques cluster patients based on their 
congregate of different depressive symptoms, without a pre-conceived hypothesis. 
Studies using latent class analysis (LCA) in depressed, younger adult populations (Kendler 
et al., 1996; Sullivan et al., 1998; Lamers et al., 2010; Li et al., 2014) identified an ‘atypical’ 
class, characterized by increased appetite and increased sleep, and a ‘typical’ (often named 
‘melancholic’) class, characterized by loss of appetite and weight, and by the presence of 
psychomotor symptoms. Subsequently, these empirically-derived classes could be linked 
to distinct biological correlates (Lamers et al., 2010, 2013; Milaneschi et al., 2015) as well as 
different genetic profiles (Milaneschi et al., 2016). 
To what extent similar subtypes can be identified in late-life major depression needs to be 
established. Some studies have implemented LCA in late-life depression (Hybels et al., 2009, 
2011, 2013; Lee et al., 2012; Mezuk and Kendler 2012), finding subtypes based mainly on 
severity. However, most of these studies also included non-depressed persons (Hybels et al., 
2009, 2013; Mezuk and Kendler 2012), or persons with at least one depressive symptom (Lee et 
al., 2012), without a formal diagnosis of major depression. Whereas inclusion of subthreshold 
depressive disorders may generate insight into the heterogeneity of depression, it impedes 
examination of the assumed heterogeneity of particularly major depressive disorder (MDD). 
Furthermore, in populations with depression of varying severity, data-driven techniques are 
at risk to detect classes that are mainly driven by different levels of severity. Furthermore, 
because most studies included persons from community samples, no insight was provided 
into clinical (outpatient) populations (Lee et al., 2012; Mezuk and Kendler 2012; Hybels et 
al., 2013). Lastly, previously demonstrated in younger depressed adults, a differentiation 
between increased or decreased appetite, weight and/or sleep served as a core feature for 
differentiation between atypical and melancholic subtypes (Kendler et al., 1996; Sullivan et 
al., 1998; Lamers et al., 2010; Li et al., 2014). However, few studies among older, depressed 
persons distinguished between increased and decreased appetite, weight and sleep 
(Hybels et al., 2009, 2013; Lee et al., 2012), and the majority of data-driven studies in the 
older population identified subtypes primarily based on depression severity only (Hybels et 
al., 2009, 2011; Mezuk and Kendler 2012). 
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Therefore, this study aimed to gain more insight into the assumed heterogeneity of 
MDD in older persons by performing LCA, based on depressive symptoms. If distinct 
classes are identified, these are examined to establish whether they differ with respect 
to demographic and clinical characteristics, as well as other risk factors and comorbidity 
patterns.
Methods
Sample
Data were derived from the baseline measurements of the Netherlands Study of Depression 
in Older persons (NESDO), a longitudinal multi-site naturalistic cohort study, examining 
the course and consequences of depression in older people. The NESDO cohort (n=510) 
consists of persons aged 60-93 years, including 378 persons with a depressive disorder in 
the previous 6 months, and 132 non-depressed controls. Depressed older persons were 
recruited from both mental health care institutes and general practitioners in five regions 
in the Netherlands, in order to include persons with current late-life depression in various 
developmental and severity stages. Depression included a 6-month diagnosis of Major 
Depressive Disorder (MDD) (95%) and/or 6-month Dysthymic Disorder (26.5%), or minor 
depression (two to four depressive symptoms lasting at least two weeks, 5.0%) according 
to DSM-IV-R criteria. Age-of-onset of depression did not serve as an selection criterion. Non-
depressed older persons were recruited from general practices and were included when no 
lifetime diagnosis of depression was present. Exclusion criteria are (suspected) dementia, 
and insufficient command of the Dutch language. The study design of NESDO is described 
in detail elsewhere (Comijs et al., 2011).
For the current study, we selected all persons with a 6-month DSM-IV diagnosis of major 
depression, as assessed with the Dutch version of the Composite International Diagnostic 
Interview (CIDI) lifetime version 2.1 (World Health Organization 1997; Andrews and Peters 
1998). The CIDI was conducted by specially trained clinical research staff. Persons with a 
diagnosis of minor depression (n=13) or dysthymia only (n=6) were excluded. In addition, 
individuals with incomplete data on CIDI items for depressive disorder were excluded (n=10), 
thus retaining a data set of 359 persons. Attrition was non-differential with respect to age 
and gender but, compared to included persons, individuals with missing data had more 
years of education (OR 1.55; 95% CI 1.06-2.17) and lower severity of depression, as measured 
by the Inventory of Depression Symptomatology (IDS) (OR 0.21; 95% CI 0.13-0.36). 
Method
Assessment of indicator variables for LCA items 
Ten depressive symptoms (Table 1) were used as indicator variables in the LCA analyses, 
including the depression key symptoms of the DSM-IV as assessed with the CIDI (World 
Health Organization 1997; Andrews and Peters 1998). The items were coded as ‘not 
present’ or ‘present’, except for the four items regarding change in appetite, weight, sleep 
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and psychomotor disturbance. For these latter items, four categories were created and 
coded as ‘no change’, ‘decrease’, ‘increase’ or ‘both increase and decrease’. 
Finally, in order to check the assumption of local independence, required for LCA, we 
examined the magnitude of bivariate correlation using Spearman’s rho. Correlations ranging 
from <0.001 to 0.29 were found. Since these correlations are only small to moderate, we 
assume that the assumption of local independence for LCA was sufficiently met.
Subject characteristics 
Classes were characterized using sociodemographic and clinical characteristics. 
Sociodemographic variables included age, gender and years of education. Clinical 
characteristics included age-of-onset of the depressive disorder, presence of a 6-month 
comorbid anxiety disorder, severity of depressive symptoms as assessed with the 30-
item Inventory of Depressive Symptomatology (IDS) (Rush et al., 1996), and apathy as 
assessed with the Apathy Scale (Starkstein et al., 1992). Psychosocial variables included 
overall functioning, personality measures, childhood adversity, and life events, all as 
continuous measurements. Overall functioning was measured with the World Health 
Organization Disability Assessment Schedule II (WHODAS) (Chwastiak and Von Korff 2003; 
Buist-Bouwman et al., 2008). Personality measures included levels of neuroticism and 
extraversion, assessed using the Neo Five-Factor Inventory (NEO-FFI) (Costa and McCrae 
1995; Hoekstra et al., 1996). Childhood adversity/trauma was assessed using a structured 
inventory derived from a Dutch longitudinal cohort study (NEMESIS) (De Graaf 2002). An 
index (range 0-4) was constructed incorporating the occurrence and frequency of 4 types 
of abuse before age 16 years (emotional neglect, psychological abuse, physical abuse, 
and sexual abuse). The number of negative life events in the last year was assessed by the 
Brugha questionnaire (Brugha 1985). Physical health indicators included current smoking 
status (current versus not smoking), pain, body mass index (BMI), metabolic syndrome, 
presence of cardiovascular disease, and ankle brachial pressure index. Pain was measured 
using the number of pain locations (range 0-7) listed in the Chronic Graded Pain scale 
(Von Korff 1992). Height and weight were measured and BMI was calculated as kilograms 
divided by meter squared. In addition, both the presence of metabolic syndrome (yes/
no) and its individual components were measured, including waist circumference, plasma 
triglycerides, plasma high-density lipoprotein cholesterol (HDL-cholesterol), blood 
pressure and fasting plasma glucose. Cut-off values for metabolic syndrome were based 
on the adjusted Adult Treatment Panel (ATP III) criteria (Expert panel 2001), including 
waist circumference ≥ 88 cm, triglycerides ≥ 150 mg/dl, HDL-cholesterol < 50 mg/dl, 
systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg or use of 
antihypertensive drugs, fasting blood glucose ≥ 100 mg/dl or use of a hypoglycemic drug. 
Persons scoring positive on ≥ 3 criteria were considered to have a metabolic syndrome. 
Diabetes was defined as fasting plasma glucose level ≥ 7.0 mmol/l. The presence of 
cardiovascular disease was determined as assessed by self-report of coronary disease, 
angina pectoris, heart failure or a history of stroke, supported by appropriate medication 
use or being currently under treatment by a physician (see Vogelzangs et al., 2010 for 
details). Ankle brachial pressure index was used as an indicator of possible peripheral 
vascular disease.
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Statistical analysis
LCA was performed, using Mplus version 5 (Muthén and Muthén 2007). Free from any a 
priori assumptions, data-driven techniques such as LCA cluster persons based on a given 
outcome. LCA, often described as a ‘categorical equivalent’ of factor analysis, assumes 
that an unobserved, latent categorical variable explains the association among a set of 
observed symptoms, like depressive symptoms. Data-driven calculations start with one 
class, suggesting one classification fitting for all persons. The persons are then successively 
allocated to an ascending number of classes, here up to 5 classes. To determine the 
number of classes best fitting the data, we examined the Bayesian Information Criterion 
(BIC), sample size adjusted BIC (ssaBIC), entropy, the Lo-Mendell-Rubin likelihood ratio 
test (LMR), the bootstrapped likelihood ratio test (BLRT), the proportion of respondents in 
each computed class, and the interpretability and clinical relevance of the latent classes. 
Of the traditionally used ‘information criteria’, the BIC performs best (Nylund et al., 2007). 
Lower BIC and ssaBIC values indicate better model fit. The Lo-Mendell-Rubin test (LMR) 
provides a p-value, which indicates whether the k-1 class model is rejected in favor of the 
k class model. Entropy, as a measure of the quality of classification, is presented for models 
with more than one class. Values for entropy can range from 0 to 1, with values closer to 1 
indicating greater classification accuracy. In order to identify clinically relevant classes, we 
aimed to identify classes greater than 5% of the sample. Currently there is no consensus as 
to which criterion best identifies the best fitting number of classes, although reasons exist 
to regard the BLRT as superior compared to other parameters of fit (Nylund et al., 2007). 
After identification of the classes and assignment of participants to their most likely class, 
the probability of occurrence of each depressive symptom per class was examined using 
Cramer’s V as a measurement of a symptom’s distinguishing power. Next, the distribution 
of the aforementioned characteristics across the identified classes was examined, using 
two-tailed chi-square statistics for categorical variables, one-way-analysis of variance 
statistics (ANOVA) for continuous variables, and Kruskal-Wallis tests for nonparametric 
continuous variables. Additional comparisons were performed to test for differences 
between pairs of classes. Multinomial logistic regression analyses were conducted to 
examine multivariable determinants of identified classes. All models were first adjusted 
for sociodemographic items (age, gender, years of education), with additional adjustment 
for all variables being significantly associated in bivariate analyses. For this purpose, a 
p-value <0.10 was considered statistically significant. All comparisons were conducted 
using SPSS version 21.0 for Windows (51). 
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Results
The total sample consisted of 359 depressed older people, of whom 66.0% were females, 
with a mean age of 70.5 (± SD 7.4) years and a mean age of depression onset of 48.5 (± SD 
20.3) years.
Considering the various parameters of fit (data available upon request), the best-fitting 
model was the three-class model, with the lowest ssaBIC (4593.2) and a significant 
BLRT (p<0.001). From the four-class model onwards, the BLRT was no longer significant, 
indicating that adding more classes to the model did not improve model fit. Although 
some parameters pointed at a two-class model (highest entropy = 0.87; lowest BIC 
4724.1; and a significant LMRT; p=0.001), the superiority of the BLRT has been reported 
(Nylund et al., 2007). In addition, the two-class model lumped together the moderate and 
melancholic class and was, therefore, considered clinically less relevant. 
Table 1 shows the probability of the occurrence of different depressive symptoms in 
the three identified latent classes. The first class (prevalence 15.0%) showed a symptom 
pattern with the highest occurrence of both weight gain and increased appetite. The 
second class (prevalence 38.4%) was characterized by the highest occurrence of weight 
loss, decreased appetite, less sleep, and psychomotor changes. The third class (prevalence 
46.5%) had the lowest occurrence of all ten depressive symptoms; hereafter, these classes 
are labeled “atypical”, “melancholic” class, and “moderate severe” class, respectively. 
Although these labels resemble specific DSM specifiers, we explicitly do not intend to 
refer to these DSM specifiers. These labels were chosen to facilitate comparisons with 
previous data-driven studies in younger adults, finding a comparable class that has been 
dubbed ‘atypical’ (Lamers et al., 2010; 2013; 2015; Rodgers et al. 2014; Alexandrino et al. 
2015). Strong distinguishing symptoms between classes were weight (Cramer’s V= 0.59) 
and appetite (Cramer’s V=0.79) and, to a lesser extent, psychomotor changes (Cramer’s 
V=0.26) and loss of interest (Cramer’s V=0.25). 
Table 2 shows the sociodemographic and clinical characteristics of the three identified 
latent classes. Within the severe atypical class, there was a preponderance of females, with 
a slightly lower mean age compared to both other classes (p=0.002). The moderate class 
had the lowest depression severity and the lowest number of current anxiety disorders, 
confirming the lower severity in this class. There were no significant group differences 
for the psychosocial variables. As for physical health characteristics, metabolic syndrome 
was most prevalent within the atypical class, and least prevalent within the melancholic 
class (p=0.003). BMI was significantly higher in the severe atypical class compared to 
both the severe melancholic and moderate class (p<0.001). Presence of heart disease was 
significantly lower in the melancholic class compared to both other classes. 
To evaluate whether characteristics were independently associated with class 
membership, multinomial logistic regression analyses were performed, comparing the 
two severe classes with the moderate class, and the two severe classes with each other 
(Table 3). Analyses were first adjusted for sociodemographic items (gender, age, years of 
education) and for variables that differed across classes in bivariate analyses with a p-value 
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=< 0.10, including age-of-onset, depression severity, presence of 1-year anxiety diagnosis, 
presence of heart disease and BMI. To avoid multicollinearity, metabolic syndrome was not 
included as this was highly correlated to both BMI (rs=0.52, p<0.001) and cardiovascular 
disease (rs=0.12, p=0.03). Using post-hoc tests we explored whether the results would 
differ if BMI and cardiovascular disease were replaced by metabolic syndrome; however, 
the results were similar. In the fully adjusted models, female sex (OR=4.57; 95% CI=1.96-
10.66), lower age (OR=0.57; 95% CI=0.38-0.88), and higher BMI (OR=1.66; 95% CI=1.17-
2.36) were significantly associated with the atypical class as compared to the moderate 
class. Likewise, female sex (OR=2.93; 95% CI=1.22-7.05), lower age (OR=0.63, 95% CI=0.41-
0.98), higher BMI (OR=2.38; 95% CI=1.63-3.48) and cardiovascular disease (OR=2.78; 
95% CI=1.09-7.09) were significantly associated with the atypical class as compared to 
the severe melancholic class. On the other hand, higher depression severity (OR=1.33; 
95% CI=1.03-1.73), a lower BMI (OR=0.70; 95% CI=0.52-0.93) and a lower number of 
cardiovascular disease (OR=0.41; 95% CI=0.20-0.83) were significantly associated with 
melancholic class, as compared to the moderate class.
Since both BMI and metabolic syndrome showed a significant difference between groups, 
and since atypical depression is thought to be associated with metabolic syndrome 
(Lamers et al., 2010; Vogelzangs et al., 2011; Mansur et al., 2015), in post-hoc analyses we 
further explored the association between the separate criteria of metabolic syndrome 
and class membership (Table 4). Multinomial logistic regression analyses were performed 
to compare both severe classes with the moderate class, and the severe classes with 
each other. The covariates used were similar to those used in Table 3, except for BMI. The 
prevalence of metabolic syndrome was significantly higher in the atypical class compared 
to both the melancholic class (OR=3.12; 95% CI=1.52-6.40) and the moderate class 
(OR=2.08; 95% CI=1.02-4.22). A higher waist circumference was significantly higher in the 
atypical class compared to both the melancholic class (OR=1.84; 95% CI=1.27-2.66) and 
the atypical class (OR=1.44; 95% CI=1.01-2.06). Higher systolic blood pressure (OR=1.44; 
95% CI=1.01-2.05) was significantly associated with the atypical class, as compared to the 
melancholic class. A lower blood glucose was significantly associated with the melancholic 
class (OR=0.64; 95% CI=0.47-0.86) as compared to the moderate class. 
Next, to examine whether weight gain was induced by antidepressant use, instead of 
being an indicator of a specific depression subtype, we performed post-hoc analyses to 
explore whether including current antidepressant in the multivariate analyses had any 
significant effect on the odds ratios. Antidepressants included were selective serotonin-
reuptake inhibitors (ATC-code N06AB), non-selective monoamine reuptake inhibitors (ATC-
code N06AA), non-selective monoamine oxidase inhibitors (ATC-code N06AF), or other 
antidepressants (ATC-code N06AX). Prevalence of current antidepressant use was 72.1% 
in the entire population, 63% in the atypical subtype, 81.9% in the melancholic subtype, 
and 67.1 in the moderate subtype (χ2(df)=11.88(4), p=0.02). After additional adjustment 
of regression analyses for antidepressant use, odds ratios remained largely similar (results 
available upon request). In contrast to the expectations, that antidepressant use may 
induce weight gain, and hence would be associated with atypical class, antidepressant 
use was only significantly associated with melancholic class (OR=2.12; 95%CI 1.18-3.85, as 
compared to the moderate class; and OR=2.50; 95% CI 1.12-5.60, as compared to atypical 
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class). Notably, antidepressant use entailed current use, whereas lifetime depression 
symptoms served as indicator variables for the LCA. Therefore, antidepressant use were 
only included in post-hoc analyses, and not in the main analyses in this study.
Discussion
This study aimed to empirically identify distinct depressive subtypes among depressed 
older persons, and to investigate whether these subtypes differ with respect to 
sociodemographic and clinical characteristics. The most prevalent class, as identified by 
LCA, was a moderate severe class (prevalence 46.5%), followed by a severe melancholic 
class (prevalence 38.4%) and a severe atypical class (prevalence 15.0%). The strongest 
distinguishing features between the three classes were appetite and weight and, to a 
lesser extent, psychomotor symptoms and loss of interest. The severe atypical class had 
the highest prevalence of females, the lowest mean age, the highest BMI and highest 
prevalence of both cardiovascular disease and metabolic syndrome, as compared to the 
melancholic class. 
Our findings are in line with previous studies. To date, several data-driven studies have been 
performed and, although the number and symptom patterns of identified classes vary 
between studies (depending on their design/methods), there is increasing evidence that 
within the heterogeneity of depressive disorders, atypical and melancholic subtypes may 
constitute clinically relevant subtypes (Kendler et al., 1996; Sullivan et al., 1998; Alexandrino 
et al., 2014; Li et al., 2014; Rodgers et al., 2014; Lamers et al., 2015). Although our atypical 
group does not exactly matches the DSM definition of atypical depression, we found 
similar symptoms (increased weight and appetite), characteristics (higher prevalence of 
female, lower mean age, lower age-of-onset) and co-occurring pathophysiology (higher 
prevalence of metabolic syndrome). Furthermore, previous data-driven studies have 
found similar classes, labeling them atypical, with similar characteristics (Novick et al. 
2005; Lamers et al. 2010; Li et al. 2014; Rodgers et al. 2014; Alexandrino et al. 2014) and 
biological disturbances(Lamers et al. 2013; Lasserre et al. 2016; Rethorst et al. 2016), that 
largely correspond with the DSM-based atypical depression. This underlines the idea both 
approaches distinguish the same atypical subtype.
However, whereas most data-driven studies were performed in younger adult persons, 
data on older persons are less abundant. To our knowledge, previous data-driven studies 
in older persons were mainly community based (Lee et al., 2012; Mezuk and Kendler 2012; 
Hybels et al., 2013). Further, these studies either used appetite and weight change as one 
aggregated item (Lee et al., 2012), did not distinguish ‘increased appetite’ (Hybels et al., 
2011, 2012; Mezuk and Kendler 2012), did only use ‘decreased appetite’ and ‘weight loss’ 
(Hybels et al., 2009), or used none of these items except for ‘decreased appetite’ (Hybels 
et al., 2013). However, not including both increased and decreased appetite and weight 
may hamper identification of specific subtypes as found in adults, characterized by, e.g., 
an increase in appetite or weight (e.g. atypical subtype). Our findings extend previous 
findings by showing that in late-life depression (using disaggregated symptoms) an 
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atypical and a melancholic subtype can be distinguished, and a relation with metabolic 
disease was found. This is in line with previous findings in younger adults (Kendler et al., 
1996; Sullivan et al., 1998; Lamers et al., 2010; Li et al., 2014). 
Considering the distribution of the classes identified with LCA, our prevalence rates 
seem to differ from previous studies that also investigated disaggregated symptoms in 
LCA. Studies in younger adults demonstrated a relatively higher prevalence of atypical 
depression, with rates as high as 24.6% (Lamers et al., 2010, 2012; Rodgers et al., 2013). 
Since increased appetite and weight gain are prominent differentiating features 
to identify atypical depressive subtypes (Lamers et al., 2010, 2013; Li et al., 2014), 
frequently occurring frailty in older persons, being associated with weight loss (and the 
development of depression) (Andrew and Rockwood 2007; Hegeman et al., 2012; Collard 
et al., 2014, 2015a, 2015b), may impact on prevalence rates of atypical subtypes in this 
population. Second, the prevalence of moderate severe depression is about 1.5 times as 
high in our older sample (46.5%) compared to younger adult studies [prevalence rates: 
29.1-34.2% (Lamers et al., 2012a; Rodgers et al., 2014, respectively)]. This is in line with 
previous findings indicating that depression may become less severe with age, although 
these latter findings are based on the DSM criteria (Judd et al., 2002; Fiske et al., 2009). 
Alternatively, depressive symptom endorsement may change across ages, resulting 
in lower depression severity on instruments validated for use in younger adults and, 
hence, the risk of underestimating depression severity in older persons. For example, a 
decline of DSM-IV symptoms (such as guilt and anhedonia) was shown in older persons as 
compared to younger adults (Caine et al., 1994; meta-analysis Hegeman et al., 2012). Since 
these items are at the core of commonly used instruments like the Montgomery-Asberg 
Depression Rating Scale (MADRS) and the Hamilton Rating Scale for Depression (HDRS), it 
is conceivable that this influences measurement of the level of severity in older persons. 
Finally, late-onset depression may be of a different nature than early-onset depression. 
Whereas early-onset depression may be characterized by a relatively higher percentage 
of atypical depression, the pathogenesis and phenomenology of late-onset depression 
may differ, therefore reducing the proportion of atypical depression within the depressed 
older population. 
Earlier studies found a higher prevalence of psychomotor symptoms in depressed older 
persons compared to depressed younger persons, but only for agitation (Hegeman et al., 
2012), whereas we found a higher prevalence for both retardation alone and co-occurring 
with agitation. In the present cohort of depressed older persons, psychomotor symptoms 
were more prevalent than in several younger adult studies, in which the prevalence of 
psychomotor changes ranged from 46.5-59.6% (Lamers et al., 2010; Rodgers et al., 2014), 
compared to 27.6% in our study. However, we found that psychomotor symptoms were 
only moderately distinguishing features between the classes (Cramer’s V= 0.26). This is 
remarkable, since psychomotor symptoms are commonly seen as a feature of melancholic 
depression (Parker et al., 2010). An explanation for our finding might be that the MADRS 
and CIDI are unable to reliably measure psychomotor symptoms. Use of a measurement 
that focuses on psychomotor symptoms of depression, such as the CORE (Parker et al., 
1994; Parker 2007; Rhebergen et al., 2011; Attu et al., 2012), may further differentiate 
depressive subtypes. Notably, apathy differed neither across classes, whereas loss of 
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interest and psychomotor symptoms were moderately strong distinguishing features 
between classes. In clinical practice apathy may mimic psychomotor retardation or loss 
of interest, whereas our results suggest that apathy (as measured with the Apathy Scale) 
measures different clinical features/phenomena.
In the present study, the differences in characteristics found between our melancholic 
and atypical classes are in line with other studies (Schotte et al., 1997; Lamers et al., 2010, 
2012). Considering the preponderance of females in the atypical subtype, it has been 
suggested that, especially in women, obesity co-occurs with depression (Luppino et al., 
2010; Marijnissen et al., 2011; Milaneschi et al., 2014), which could explain the higher 
prevalence of females in the atypical class. The lower use of antidepressants in the atypical 
class compared to both other classes further adds to the idea that increased weight and 
appetite are part of the symptom profile rather than a result of antidepressant use. In 
post-hoc analyses we found that additional adjustment for antidepressant use did not 
alter our findings. However, our database only includes current antidepressant use, while 
we used lifetime symptoms for the determining the classes. Furthermore, in a study with a 
naturalistic design like we used, no reliable statement can be made regarding the impact 
of antidepressant use. Lastly, we used a cross-sectional design, making it impossible 
to draw causal inferences. Although the lower age within the atypical group is also in 
accordance with others (Angst et al., 2002; Novick et al., 2005; Halbreich and Kahn. 2007; 
Lamers et al., 2010), an explanation for this is lacking. 
Finally, notable findings are the low prevalence of cardiovascular disease within the 
melancholic class, and the high prevalence of metabolic syndrome within the atypical class. 
Studies including younger adults also found a higher prevalence of metabolic syndrome 
within atypical depression (Lamers et al., 2010, 2013; Vogelzangs et al., 2014), but did not 
find a higher number of cardiovascular diseases. It is possible that atypical depression, 
which more often co-occurs with metabolic syndrome at a younger age, constitutes a 
phenotype with a higher risk of cardiovascular disease at an older age. In younger adults, 
studies have found that treating components of metabolic syndrome might also benefit 
depressive symptoms: persons with atypical depression benefit the most from exercise 
(Rethorst et al. 2016), and addition of the anti-inflammatory drug celecoxib lowers IL-6 
rates (Abbasi et al. 2012), which are elevated in atypical depression (Lamers et al. 2013). 
Our finding stresses the importance of preventive cardiovascular management in persons 
with atypical depression, as well as studies on the effect of treating metabolic syndrome 
components and inflammation in depressed older persons.
The results of this study should be interpreted in the context of various strengths and 
limitations. A strength is that this study is the first to demonstrate depression subtypes, 
both in severity and symptom profile, in an older population with major depression. In 
addition, a wide selection of characteristics were examined. 
However, some limitations also need to be addressed. The strongest distinguishing 
symptoms between classes were weight (Cramer’s V= 0.59) and appetite (Cramer’s V=0.79). 
One could argue that (in theory) these constructs are highly correlated, as was also the case 
in a study using factor mixture modelling (an extension of LCA) in a general population 
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sample (Ten Have et al., 2016); however, the correlation coefficient was small (rs =0.293). 
Albeit this seems counterintuitive, we hypothesize that, in older persons, these putative 
correlating items may be less correlated than in younger adults, since weight loss is a 
common problem and is associated with a broad range of physiological and pathological 
factors in aging. Also, using weight and appetite as separate items in LCA allows comparison 
with a large body of literature on adult LCA (Kendler et al., 1996; Sullivan et al., 1998; Lamers 
et al., 2010; Hybels et al., 2012; Mezuk and Kendler 2012; Rodgers et al., 2013; Alexandrino 
et al., 2014). However, despite potential issues with violation of the local independence 
assumption in adult studies, atypical and melancholic subtypes found in these latter studies 
had differential biology (Mansur et al., 2011; Lamers et al., 2013; Liu et al., 2014; Vogelzangs et 
al., 2014) and genetic differences (Milaneschi et al., 2016), highlighting the relevance of the 
distinction by appetite and weight. Further, due to the cross-sectional design of the study, it 
remains unknown to what extent the identified classes are stable over time. In addition, the 
lack of a comparison group of persons in the same age cohort without current depression 
limits thorough examination to what extent current depression state or age may impact 
on the identified classes, based on lifetime symptoms. However, studies in younger adults 
demonstrated a high diagnostic stability of LCA-derived subtypes (Lamers et al., 2012b; 
Rodgers et al., 2013), with especially great stability of the atypical class ranging from 70-
79%, thus suggesting etiologically distinct entities. Schaakxs et al. (2017) found stability of 
depression severity with aging, albeit with different symptom prominence. Symptoms more 
prominent in older age were early awakening and problems with sleeping during the night, 
while symptoms occurring more often in younger age were interpersonal sensitivity and 
sleeping too much. Future longitudinal studies should examine whether classes are stable 
over time in older adults, too. 
In addition, persons with missing data had lower depression severity and a higher 
education level. Had they not been excluded, they would probably have been allocated 
to the moderate class; this would have had an impact on the distribution of classes. 
Regarding education, the attrition presumably does not impact our findings, as there was 
no significant difference in education across the classes.
To conclude, this study applied data-driven methods to identify classes of depressive 
disorder in a large cohort of older persons. In line with studies in younger adults, three 
classes were identified (i.e. an atypical, melancholic and moderate severe depression), with 
appetite and weight being the main distinguishing features. The increased prevalence 
of metabolic syndrome within the atypical class, and the decreased prevalence of 
cardiovascular disease within the melancholic subtype (the latter not previously found in 
younger adult populations) illustrates the importance of differentiating into depressive 
subtypes, particularly in the older population. Furthermore, differentiation into depressive 
subtypes in late-life depression may facilitate further research on the underlying etiology 
of depression, the role of metabolic abnormalities, and the predictive value of subtypes 
on treatment response. 
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Table 1. Estimated symptom profile probabilities of endorsing depressive symptoms from LCA (n=359)
Class Description
Total 
sample
Class 1,
Severe 
atypical
Class 2,
Severe 
melancholic
Class 3,
Moderate 
severity
Cramer V 
Statistic P-value(df)
Prevalence
359 
(100%)
54
(15.0%)
138
(38.4%)
167
(46.5%)
DSM-IV criterion symptoms
Depressed mood 0.97 0.94 1.00 0.95 0.14 0.028(2)
Loss of interest 0.92 0.96 0.99 0.86 0.25 <.001(2)
Weight 0.59 <.001(8)
 No weight change 0.57 0.54 0.27 0.84
 Weight loss 0.34 0.00 0.71 0.14
 Weight gain 0.06 0.37 0.01 0.00
Both gain and loss 0.03 0.09 0.01 0.02
Appetite 0.79 <.001(8)
 No change in appetite 0.30 0.04 0.02 0.61
 Decreased appetite 0.53 0.00 0.92 0.38
 Increased appetite 0.12 0.80 0.00 0.00
Both increase and decrease 0.05 0.17 0.06 0.01
Sleep 0.16 0.004(8)
 No change in sleep 0.10 0.09 0.04 0.14
 Less sleep 0.60 0.48 0.66 0.59
 More sleep 0.08 0.06 0.09 0.08
 Both less and more sleep 0.22 0.37 0.22 0.17
Psychomotor 0.26 <.001(8)
 No psychomotor change 0.28 0.28 0.11 0.41
 Psychomotor retardation 0.30 0.24 0.33 0.30
 Psychomotor agitation 0.15 0.17 0.17 0.16
 Both agitation and 
retardation 0.26 0.32 0.39 0.13
Fatigue/energy loss 0.91 0.94 0.98 0.84 0.22 <.001(2)
Guilt/worthlessness 0.79 0.85 0.87 0.71 0.19 0.002(2)
Concentration/
indecisiveness 0.96 1.00 0.98 0.94 0.12 0.063(2)
Suicidal ideation 0.69 0.70 0.79 0.59 0.20 0.001(2)
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Table 2. Characteristics of latent classes (n=359)
Total 
sample
Class 1,
Severe 
atypical
(n=54)
Class 2,
Severe 
melancholic 
(n=138)
Class 3,
Moderate 
severity
(n=167)
Χ2, F, (df), 
overall
P-value
Prevalence
359 (100%)
54 (15.0%) 138 (38.4%) 167 (46.5%)
Sociodemographics
Sex, female, % 66.0 83.3 68.8 58.1 12.39(2), 0.0021
Age, mean (SD), years 70.5(7.4) 68.3(6.7) 70.5(7.1) 71.5(7.7) 3.95(2), 0.022
Education, mean (SD), years 10.4(3.4) 11.0(3.7) 10.1(3.2) 10.4(3.4) 1.21(2), 0.302
Clinical characteristics
Age onset, mean (SD) years 48.5(20.3) 41.7(20.7) 49.6(19.1) 49.9(20.8) 3.58(2), 0.042
Severity (IDS), mean (SD) 30.5(13.0) 32.2(11.8) 32.6(14.2) 28.0(11.8) 5.20(2), 0.012
Presence 1 year anxiety 
diagnosis, % 40.1 38.9 48.6 33.5 7.13(2), 0.031
Apathy, mean (SD) 17.2(5.6) 17.2(5.9) 17.2(5.7) 17.3(5.5) 0.02(2), 0.982
Psychosocial
Functioning, mean (SD) 33.3(15.8) 34.7(16.4) 35.0(16.3) 31.4(15.2) 2.23(2), 0.122
Neuroticism, mean (SD) 39.0(7.0) 40.3(7.2) 38.7(6.7) 38.8(7.3) 1.00(2), 0.372
Extraversion, mean (SD) 33.7(6.5) 34.3(6.9) 34.2(6.8) 33.2(6.2) 0.79(2), 0.462
Childhood trauma index, 
mean (SD) 1.0(1.2) 1.2(1.3) 1.1(1.2) 0.9(1.2) 1.75(2), 0.182
No. negative life events, 
median (IQR) 0.0(1) 0.0(1) 1.0(1) 0.0(1) 3.94(2), 0.143
Physical health
Current smoking, % 27.0 31.5 26.5 26.5 0.64(2), 0.751
Chronic pain grade, median 
(IQR) 2.00(2) 2.00(3) 2.00(2) 2.00(2) 4.90(2), 0.093
Presence of metabolic 
syndrome, % 44.0 63.0 35.5 44.9 11.98(2), <0.011
Body mass index, median (IQR) 26.3(4.4) 27.7 (5.9) 25.3 (5.65) 25.3 (5.32) 23.74(2), <0.013
Cardiovascular disease, % 17.8 24.1 10.1 22.2 9.13(2), 0.011
Diabetes, % 12.8 11.1 9.4 13.9 1.35(2), 0.481
Ankle brachial index, median 
(IQR) 1.1(0.2) 1.1(0.4) 1.1(0.2) 1.1(0.2) 0.37(2), 0.833
Tests used: 1Chi-square (χ2); 2Anova (F); 3Kruskal-Wallis (χ2)
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Table 3. Odds Ratios and 95% CIs for the Multivariable Comparison of the three Latent Classes (N=359)
Comparison of severe classes to 
moderate class (=reference) Severe Atypical vs 
Severe Melancholic 
(=ref)
OR (95% CI)
Severe Atypical,
OR (95% CI)
Severe Melancholic,
OR (95% CI)
Sociodemographics
Female 4.55(1.95-10.59) 1.60(0.94-2.71) 2.93(1.22-7.05)
Age 0.58(0.38-0.89) 0.90(0.69-1.19) 0.65(0.42-1.00)
Education in years 1.38(0.96-2.00) 1.02(0.79-1.33) 1.35(0.93-1.97)
Clinical characteristics
Age of onset 0.81(0.56-1.18) 1.03(0.78-1.35) 0.79(0.54-1.16)
Presence 1-year anxiety diagnosis 0.87(0.42-1.82) 1.47(0.87-2.48) 0.55(0.26-1.15)
Severity 0.95(0.65-1.40) 1.33(1.03-1.73) 0.71(0.48-1.06)
Antidepressant use 1.17(0.49-2.58) 2.12(1.18-3.85) 2.50(1.12-5.60)
Physical health
Chronic pain grade 1.20(0.82-1.76) 1.10(0.83-1.44) 1.09(0.74-1.62)
Body mass index 1.67(1.18-2.36) 0.68(0.51-0.91) 2.45(1.67-3.59)
Cardiovascular disease 1.13(0.49-2.58) 0.44(0.21-0.89) 2.58(1.00-6.64)
Corrected for every other item in the table: gender, age, years of education, age of onset, presence of 1-year 
anxiety diagnosis, severity, antidepressant use, chronic pain grade, body mass index, cardiovascular disease. 
Exp(B) and 95% CI for Exp(B)
Table 4. Odds Ratios and 95% CIs for Metabolic Syndrome and the Separate Criteria (N=359)
Comparison of severe classes to 
moderate class (=reference) Severe Atypical vs 
Severe Melancholic 
(=ref ),
OR (95% CI)
Severe Atypical,
OR (95% CI)
Severe Melancholic,
OR (95% CI)
Metabolic syndrome 2.08(1.02-4.22) 0.63(0.38-1.05) 3.32(1.60-6.88)
Waist circumference 1.44(1.01-2.06) 0.76(0.57-1.01) 1.89(1.30-2.76)
Triglycerides 1.08(0.77-1.52) 1.02(0.79-1.32) 1.06(0.75-1.49)
HDL cholesterol 0.89(0.62-1.28) 1.03(0.80-1.33) 0.85(0.59-1.22)
Systolic pressure 1.24(0.87-1.76) 0.85(0.66-1.10) 1.45(1.02-2.08)
Diastolic pressure 1.21(0.84-1.72) 0.88(0.68-1.14) 1.37(0.96-1.96)
Blood glucose 0.73(0.50-1.07) 0.64(0.48-0.87) 1.14(0.75-1.75)
Corrected for variables in Table 3 except BMI: gender, age, years of education, age of onset, presence of 
1-year anxiety diagnosis, severity, antidepressant use, chronic pain grade and presence of cardiovascular 
disease
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Background: There is growing evidence that inflammatory and cortisol dysregulation are 
underlying pathophysiological mechanisms in the aetiology of major depressive disorder, 
particularly in younger adults. However, findings of biological disturbances in late-life depression 
have been divergent, probably due to the even greater heterogeneity of depression in older adults 
with aging processes influencing biological factors. Using empirically derived subtypes may enable 
the identification of biological disturbances underlying depression in older adults.
Methods: Data were used from the Netherlands Study of Depression in Older Persons (NESDO) 
of 359 persons aged 60 years or older, with a current diagnosis of major depressive disorder 
(MDD). Depressive subtypes (severe atypical, severe melancholic, and moderate severe subtype) 
that were previously identified through latent class analysis (LCA), were examined on differences 
in inflammatory markers including C-reactive protein (CRP), interleukin-6 (IL-6), and neutrophil 
gelatinase-associated lipocalin (NGAL), as well as cortisol parameters.
Results: No differences in measures for inflammation and cortisol across subtypes were observed in 
uncorrected or for putative confounders corrected models. 
Limitations: Several subjects had missing cortisol and inflammatory data, decreasing the power. 
However, results did not change after imputation analysis.
Discussion: In this cohort of depressed older adults, no differences in inflammation and cortisol 
measures between depression subtypes were observed. This is probably due to the many (patho)
physiological processes that are involved in aging, thereby clouding the results. 
Key words: latent class analysis; depression subtypes; inflammation; cortisol; atypical depression; 
melancholic depression
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Background
Major depressive disorder is a common disease, with prevalence rates in the older 
population ranging from 1-16% (Djernes 2006). However, the aetiology and pathogenesis 
of major depressive disorder remain largely unknown. Studies have suggested that 
possible underlying biological mechanisms include disturbances in inflammation 
pathways and the hypothalamic-pituitary-adrenal (HPA)-axis, which could predict course 
and treatment response (Berk et al., 2013; Miller et al., 2015; Martinez et al., 2016; Zalli et 
al., 2016). However, to date findings are inconsistent.
Regarding inflammatory markers such as C-reactive protein (CRP) and interleukin-6 (IL-
6), studies in older depressed adults have found mainly higher inflammatory markers 
in depressed persons compared to healthy controls (Biggelaar et al., 2007; Bremmer et 
al., 2008; Martinez et al., 2016). A meta-analysis concluded that of several inflammation 
markers, only IL-6 had a consistent positive correlation with late-life depression (Martinez 
et al., 2016). Findings on cortisol measures in older depressed persons are inconsistent 
too, with some studies finding higher cortisol measures (Balardin et al., 2011; Kuo et al., 
2011; Belvederi Murri et al., 2014; Rhebergen et al., 2015), whereas others reported a 
U-shaped association between cortisol and depression in older adults (Bremmer et al., 
2007; Penninx et al., 2007).
There are indications that these inconsistent findings might be due to the considerable 
heterogeneity of depression in older adults, stressing the importance of subtyping 
depression when researching underlying pathophysiological mechanisms. Within 
younger adults, inflammatory and cortisol dysregulations have been linked to specific 
subtypes of depression (Gold and Chrousos 2002; Stetler and Miller 2011; Lamers et al., 
2013; Penninx et al., 2013). A melancholic subtype, identified by data-driven techniques, 
was linked to higher cortisol measures compared to other subtypes and healthy controls. 
An atypical subtype, characterized by increased appetite and weight, was linked to 
increased inflammatory markers (Lamers et al., 2013), and seemed to have a differential 
genetic profile (Milaneschi et al., 2016). Within older people, there are indications as well 
that the degree and quality of biological dysregulation may be correlated with both the 
severity of depression (Viinamäki et al., 2009; Duivis et al., 2011; Kahl et al., 2012) and 
depression characteristics (Vogelzangs et al., 2014). Data-driven subtypes of depression 
in older adults have been identified previously (Hybels et al., 2009; Lee et al., 2012; Mezuk 
& Kendler 2012; Veltman et al., 2017), but research on biological disturbances within these 
subtypes is lacking.
Therefore, to gain more insight into the role of immunometabolism and functioning of 
the HPA-axis within depressed older adults, we examined inflammatory markers and 
cortisol parameters within different subtypes of depression, as determined previously 
in this cohort of older people by latent class analysis (LCA) (Veltman et al., 2017). We 
hypothesized that inflammatory markers are higher in the atypical subtype compared to 
the other subtypes, and that cortisol parameters are higher in the melancholic subtype of 
depression. 
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Methods
Sample
Data were derived from the baseline measurements of the Netherlands Study of 
Depression in Older persons (NESDO), a longitudinal multi-site naturalistic cohort study, 
examining predictors of the course and consequences of depression in older people. The 
NESDO cohort (n=510) consists of persons aged 60-93 years, including 378 persons with 
a depressive disorder in the previous 6 months, and 132 non-depressed controls. The 
study protocol of NESDO has been approved centrally by the Ethical Review Board of the 
VU University Medical Center, and subsequently by the local ethical review boards of all 
participating universities. Written informed consent was obtained from all participants 
at the start of the baseline assessment. The study design of NESDO is described in detail 
elsewhere (Comijs et al., 2011).
For the current study, we selected all persons with a 6-month DSM-IV diagnosis of major 
depression (n=359), as assessed with the Dutch version of the Composite International 
Diagnostic Interview (CIDI) lifetime version 2.1 (World Health Organization 1997; Andrews 
& Peters 1998). The CIDI was conducted by trained clinical research staff. None of the 
participants used corticosteroids. Seventy-seven persons had missing data on all cortisol 
measures and were excluded from the cortisol analyses. Ten persons had missing data 
on all inflammatory markers and were excluded from the inflammation analyses. Four 
persons had missing values on all inflammatory markers and cortisol measures, and 
were excluded from all analyses, thus retaining a final study population of 355 persons 
on baseline characteristics, 349 persons on inflammatory markers, and 282 persons on 
cortisol measures. Attrition was non-differential with respect to sex, age, education level, 
severity of depression, and subtype of depression.
Depressive subtypes
The subtypes previously identified in this cohort by LCA were used. For a detailed 
description we refer to Veltman et al., (2017). In short, ten depressive symptoms were 
used as indicator variables in the LCA analyses, including the depression key symptoms 
of the DSM-IV as assessed with the CIDI (World Health Organization 1997; Andrews & 
Peters 1998). Three subtypes were identified: a severe atypical subtype (prevalence 
15.0%), characterized by increased appetite and weight; a severe melancholic subtype 
(prevalence 38.4%), characterized by decreased appetite and weight; and a moderate 
severe subtype (prevalence 46.5%), characterized by lower symptom severity on all items. 
The subtypes are labelled “severe atypical”, “severe melancholic”, and “moderate severe” 
subtype, respectively. Although these labels resemble specific DSM specifiers, we do not 
intend to refer to these DSM specifiers. These labels were chosen to facilitate comparisons 
with previous studies (e.g. Lamers et al., 2013). 
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Biological measures
Inflammatory measures
Inflammatory markers included C-reactive protein (CRP), interleukin-6 (IL-6), and 
neutrophil gelatinase-associated lipocalin (NGAL). Fasting blood samples were obtained 
in the morning between 8 and 9 am after an overnight fast and kept frozen at -80°C. High-
sensitivity plasma levels of CRP were measured in duplicate by an immunoturbidimetric 
assay (Tina-quant CRPHS, Roche Diagnostics, Mannheim, Germany). Plasma IL-6 levels 
were measured in duplicate by a high sensitivity ELISA (PeliKine Compact™ ELISA, 
Sanquin, Amsterdam, The Netherlands). Intra- and inter-assay coefficients of variation 
were 2% and 2% for CRP, and 8% and 12% for IL-6, respectively. Plasma NGAL levels, an 
inflammatory marker earlier associated with late-life depression (Naudé et al., 2013) were 
quantified via a constructed sandwich ELISA, with the absorbance being determined at 
492nm and 620nm using an ELISA reader (Asys UVM 340, Biochrom, Cambridge, UK). 
The inter- and intra-assay coefficients of variation were 2% and 5%, respectively. For a 
detailed explanation we refer to Naudé et al., (2013). Persons with a CRP value above 
ten (N=33) were excluded, as this indicates a current inflammatory process as part of a 
somatic disease, which may interfere with a putative biological mechanism associated 
with a certain depressive subtype. 
Cortisol
Respondents were instructed to collect saliva samples at home on two consecutive 
days shortly after the interview at baseline. Instructions concerning saliva sampling 
prohibited eating, drinking tea or coffee or brushing teeth within 15 minutes before 
sampling. Furthermore, no dental work 24 hours prior to sampling was allowed. Saliva 
samples were obtained using Salivettes (Sarstedt, Germany) at six time points; at the time 
of awakening (T1), 30 minutes post-awakening (T2), 45 minutes post-awakening (T3), 60 
minutes post-awakening (T4) and at 22:00 h (T5). The salivettes were restored in the tube 
labeled with date and time. After collecting all samples, the persons were asked to return 
the samples by post to the research center. After receipt, salivettes were centrifuged at 
2000 g for ten minutes, aliquoted and stored at −80°C. Cortisol analysis was performed 
by competitive electrochemiluminescence immunoassay (E170 Roche, Switzerland). 
The  functional  detection limit was 2.5 nmol/l and the intra- and inter-assay variability 
coefficients in the measuring range were less than 10%. A random selection of 22 assays 
were repeated if cortisol measures were high (> 60 nmol/L); 19 high vales remained high 
after reassessment and the mean of the values was used. Three high values became lower 
after reassessment and were reassessed for a second time. All three remained low and the 
mean of the two low values was used. 
Cortisol awakening response
From the four saliva samples taken within 1 h after awakening (T1 to T4), we calculated 
the area under the curve with respect to the increase (AUCi) and with respect to the 
ground (AUCg) using Pruessner’s formulas (Pruessner et al., 2003). The AUCg is an estimate 
of the total cortisol secretion over the first hour after awakening, whereas the AUCi is a 
measure of the dynamics of the cortisol awakening response (CAR), more related to the 
sensitivity of the system, emphasizing changes over time after awakening (Edwards et al., 
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2001; Fekedulegn et al., 2007; Schmidt-Reinwald et al., 1999). AUCi and AUCg could be 
calculated for all persons for whom all four morning samples were available (n=335). For 
those with 1 missing morning cortisol value (n=53) the missing value was imputed using 
linear regression analyses including information on the available three cortisol measures, 
sex, age, awakening time, and smoking status (see also Vreeburg et al., 2009a; Rhebergen 
et al., 2015). After imputation, AUCs could be calculated for 267 persons. 
Diurnal slope 
Diurnal slope was calculated by subtraction of the evening sample (T5) from the sample 
at awakening (T1) resulting in the decline in cortisol levels during the day. Due to missing 
samples at T1 or T5, diurnal slope could be calculated for 400 persons.
Covariates and descriptive variables
Subtypes were characterized using sociodemographic and clinical characteristics. 
Sociodemographic variables included age, gender and years of education. Clinical 
characteristics included age of onset of the depressive disorder, presence of 1-year 
comorbid anxiety disorder, both assessed by the CIDI, and severity of depressive symptoms 
as assessed with the 30-item Inventory of Depressive Symptomatology (IDS) (Rush et 
al., 1996). Cognitive functioning was measured with the Mini Mental State Examination 
(MMSE) (Folstein et al., 1975).
Physical health indicators included smoking status; pain using the number of pain 
locations (range 0-7) listed in the Chronic Graded Pain scale (Von Korff 1992); presence 
of metabolic syndrome as assessed according to the adjusted Adult Treatment Panel 
(ATP III) criteria (Expert panel, 2001); body mass index (BMI); presence of cardiovascular 
disease as assessed by self-report of coronary disease, angina pectoris, heart failure or a 
history of stroke, and supported by appropriate medication use or being currently under 
treatment by a physician; and the use of non-steroidal anti-inflammatory drugs (NSAIDs) 
(ATC-code N02BA01), non-selective monoamine reuptake inhibitors (N06AA), selective 
serotonin reuptake inhibitors (N06AB), non-selective monoamine oxidase inhibitors 
(N06AF), monoamine oxidase A inhibitors (N06AG), or other antidepressants (N06AX). 
Daily alcohol use was measured with the Alcohol Use Disorders Identification Test (AUDIT) 
(Saunders et al., 1993). Number of chronic diseases was measured by using the LASA 
Questionnaire (Kriegsman et al., 1996). Previous literature demonstrates that a great 
variety of characteristics may act as putative confounders in the association between 
biomarkers and depression subtypes. However, in our previous studies (Veltman et al., 
2017; Rhebergen et al., 2015), we examined the association of a wide variety of psycho-
social characteristics with depression subtypes and putative confounders of HPA-axis 
functioning, respectively, in the NESDO-cohort. Characteristics that previously did not 
cause the estimate for subtypes or cortisol measures in regression analyses to change 
more than 10% were not considered as putative confounders in the current paper. 
Eveline Veltman inhoud v1.indd   46 12-12-2019   12:23:25
Inflammatory markers and cortisol parameters across depressive subtypes
3
|   47 
Statistical analysis
All analyses were performed in SPSS, version 21.0. First, levels of inflammatory markers 
and cortisol parameters were compared across groups using analyses of variance. In case 
of non-normal distributions, biological measures were natural log-transformed. If non-
normality prevailed despite transformation, Kruskal-Wallis tests were performed. 
Next, multinomial regression analyses were conducted, with depression subtypes as 
outcome. Analyses were adjusted for putative confounders, determined through adding 
all putative confounders separately to the model. Putative confounders were added to 
the final model if they caused the estimate for subtypes in regression analyses to change 
more than 10%. Despite not reaching the 10% threshold, severity was added as a putative 
confounder too, in line with earlier research that found biology measures and severity of 
depression to be correlated (Vreeburg et al., 2009b; Knorr et al., 2010; Lamers et al., 2013; 
Rhebergen et al., 2015).
Results
Table 1 shows the sociodemographic and clinical characteristics of the different subtypes 
of depression, with differences in distribution of sex, age, depression severity and onset, 
and comorbid anxiety. In addition, metabolic syndrome and BMI were higher in atypical 
depression, whereas the presence of heart disease was lower in the melancholic subtype. 
Inflammatory markers and cortisol parameters across depression subtypes did not 
differ significantly in univariate analyses (Table 1). In addition, in the and fully adjusted 
regression models, no significant associations were found between inflammatory markers 
or cortisol parameters and depression subtypes (see table 2). Post-hoc we explored 
whether results would differ if we included cases with a CRP level >10, but no subtype 
differences were found with this approach either. Since we had a considerate number of 
missing values, we did post-hoc analyses on an imputated data set, exploring whether the 
lack of significance could be explained by missingness. Multiple imputation was used for 
missings on both inflammation (CRP, NGAL, IL-6) and cortisol (AUCg, AUCi, diurnal slope), 
using all covariates and variables as used in the regression models, generating five data 
sets. However, this did not give different results (data available upon request).
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Discussion
This study aimed to examine differences in inflammatory markers and cortisol parameters 
in empirically derived subtypes of depression in older adults. Bivariate and multivariate 
analyses did not yield differences between atypical, melancholic and moderate severe 
forms of depression, neither for inflammatory markers nor cortisol parameters. 
Although several studies have examined inflammation parameters and cortisol measures 
in the older depressed population before (Belvederi Murri et al., 2014; Martinez et al., 2016), 
this has not been done using data-driven subtypes. In younger adults these parameters 
have been examined within subtypes before. The results of our study differ from several 
studies done in younger adults, demonstrating a correlation between subtypes of 
depression and both inflammatory markers (Rothermundt et al., 2001; Lamers et al., 2013) 
and cortisol parameters (Nelson and Davis 1997; Gold and Chrousos 2002; Stetler and Miller 
2011; Lamers et al., 2013). Studies on biological parameters and depression subtypes in 
older persons are scant. One study found an overall immunometabolic downregulation in 
older depressed persons, except for DSM-defined atypical depression (Vogelzangs et al., 
2014). Another study found that late-life depression is correlated with NGAL, but only in 
patients with visceral obesity (Marijnissen et al., 2014), or in patients with recurring MDD 
(Naudé et al., 2013). Within our study, the atypical subtype is characterised by a higher 
mean BMI, but no significant correlation between this subtype and NGAL was found, nor 
an overall immunometabolic downregulation in our melancholic and moderately severe 
subtypes. Hence, the scarce previous findings could not be replicated. Next, a meta-
analysis found a positive correlation between cortisol measures and late-life depression, 
especially morning cortisol, but again effects were small, and information on cortisol 
levels in depression subtypes was lacking (Belvederi Murri et al., 2014). In contrast with 
our hypothesis, we could not demonstrate an association between cortisol levels and 
depression subtypes, but due to the lack of studies in older adults on depression subtypes 
and cortisol, comparisons with other studies are hampered. 
Since depression is believed to be a heterogeneous disorder, with different 
pathophysiological processes leading to different symptom complexes, we expected that 
subtyping late-life depression would give more consistent results, similar to findings in 
younger adults (Lamers et al., 2013). However, while depression subtypes in older adults 
mimick subtypes in younger adults (Hybels et al., 2011; Veltman et al., 2017), our study 
failed to show a similar, consistent correlation between depressive subtypes and biological 
measurements. These findings suggest that the pathogenesis of depression in older adults 
may be more difficult to disentangle than that of depression in younger adults. Possibly 
both (patho)physiological processes involved in aging and/or the presence of somatic 
comorbidities and corresponding medication use may impact on biomarkers, and, 
hence, blur any association between depression subtypes and inflammatory and cortisol 
measures. Insight into depression in the older population is of paramount importance in 
order to improve diagnosis, treatment, and prediction of prognosis. However, we think 
that the current biological parameters, being involved in a vast array of processes in both 
aging and disease, are not specific enough and therefore insufficient to demonstrate the 
pathophysiological processes underlying depression in older age.
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Limitations
A limitation of this study is the missing data of cortisol measures for several subjects, 
and to a lesser extent inflammatory measures, decreasing the cohort size and thereby 
the power. However, results did not become significant after imputation analysis either 
(data available upon request). Another limitation is the lack of information regarding the 
duration of the current depressive episode.
Conclusion
To conclude, this study is the first to examine putative underlying pathophysiological 
mechanisms of previously identified, data-driven subtypes of depression, in a large cohort 
of older adults. No significant differences in inflammation markers and cortisol parameters 
across subtypes were observed. To date, studies on biological disturbances in depressed 
older adults consistently report inconsistent results, suggesting that the currently used 
biological parameters may be involved in both aging and disease processes, muddling 
insight in the pathogenesis of late-life depression. 
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Table 1. Characteristics of stable subgroups (n=359)
Total 
sample
Group 1,
Severe 
atypical
Group 2,
Severe 
melancholic 
Group 3,
Moderate 
severity
Overall
P-value(df)
Prevalence 359 (100%) 54 (15.0%) 138 (38.4%) 167 (46.5%)
Sociodemographics
Sex, female, % 66.0 83.3 68.8 58.1 0.002(2)
Age, mean (SD), years 70.5(7.4) 68.3(6.7) 70.5(7.1) 71.5(7.7) 0.02(2)
Education, mean (SD), years 10.4(3.4) 11.0(3.7) 10.1(3.2) 10.4(3.4) 0.30(2)
Clinical characteristics
Age onset, mean (SD) years 48.5(20.3) 41.7(20.7) 49.6(19.1) 49.9(20.8) 0.04(2)
Presence 1 year anxiety diagnosis, % 40.1 38.9 48.6 33.5 0.03(2)
Severity (IDS), mean (SD) 30.5(13.0) 32.2(11.8) 32.6(14.2) 28.0(11.8) 0.01(2)
MMSE score, median (IQR) 28.0(2) 28.0(2) 28.0(3) 28.0(2) 0.16(2)
Physical health
Current smoking, % 27.0 31.5 26.5 26.5 0.75(2)
Chronic pain grade, median (IQR) 2.00(2) 2.00(3) 2.00(2) 2.00(2) 0.09(2)
Metabolic syndrome, % 44.0 63.0 35.5 44.9 0.003(2)
Body mass index, median (IQR) 26.3(4.4) 27.7(5.9) 25.3(5.7) 25.3(5.3) <0.001(2)
Cardiovascular disease, % 17.8 24.1 10.1 22.2 0.01(2)
NSAID use, % 23.7 29.6 18.1 26.3 0.24(2)
Antidepressant use, % 72.1 63.0 81.9 67.1 0.02(2)
Alcohol # daily, median (IQR) 0.06(1.2) 0.03(1.2) 0.03(0.5) 0.15(1.2) 0.26(2)
# chronic diseases, mean (SD) 2.12(1.5) 2.44(1.5) 2.06(1.5) 2.07(1.4) 0.21(2)
Inflammation markers
NGAL, mean (SD)a 63.8(29.5) 57.5(20.6) 66.7(37.4) 63.6(24.0) 0.59(2)
IL-6, median (IQR)b 0.52(1.48) 0.65(1.80) 0.47(1.32) 0.52(1.7) 0.63(2)
CRP, mean(SD) 2.3(1.9) 2.7(2.1) 2.1(1.8) 2.3(1.9) 0.18(2)
Cortisol parameters
AUCg, mean (SD)a 20.0(9.8) 21.2(10.6) 20.4(9.8) 19.3(9.5) 0.49(2)
AUCi, median (IQR)b -0.2(8.3) -0.1(11.8) 0.6(8.8) -0.2(8.3) 0.94(2)
Diurnal slope T5/ T1, mean (SD)a 13.6(11.0) 14.9(10.4) 13.8(12.0) 13.0(10.5) 0.56(2)
a Normal distribution was reached after natural log transformation. Untransformed means are presented.
b Despite transformation, no normal distribution was reached
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Table 2. Odds Ratios and 95% CIs for inflammation markers (n=351) and cortisol parameters (n=294) across 
subtypes of depression in older adults 
Comparison of severe subtypes to 
moderate subtype (=reference) Severe Atypical vs 
Severe Melancholic 
(=ref),
OR (95% CI)
Severe Atypical,
OR (95% CI)
Severe 
Melancholic,
OR (95% CI)
NGALa 0.83(0.58-1.20) 0.92(0.72-1.18) 0.83(0.58-1.20)
IL-6a 1.06(0.80-1.42) 1.02(0.79-1.33) 1.04(0.80-1.34)
CRPa 1.17(0.85-1.62) 0.91(0.70-1.20) 1.29(0.92-1.80)
AUCgb 1.24(0.84-1.84) 1.13(0.85-1.51) 1.10(0.73-1.64)
AUCib 0.88(0.60-1.31) 0.91(0.68-1.21) 0.97(0.65-1.46)
Diurnal slopeb 1.30(0.92-2.08) 1.14(0.87-1.51) 1.21(0.80-1.83)
aAdjusted for gender, age, severity, use of antidepressants.
bAdjusted for gender, age, severity, smoking, amount of daylight, use of salicylacid derivate.
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Background: The heterogeneity of late-life depression hampers diagnosis and treatment. Data-
driven methods have identified several subtypes of depression in older persons, but the longitudinal 
stability of these subtypes remains unknown.
Methods: In total 111 older persons with a major depressive disorder both at baseline and 2-year 
follow-up from the Netherlands Study of Depression in Older persons (NESDO) were included. 
Latent class analysis was performed to identify subtypes of depression at baseline and at 2-year 
follow-up, and latent transition analysis was used to examine the stability of these subtypes over 
time. Transition rates between subtypes and characteristics of groups were examined. 
Results: Two subtypes were identified in both baseline (T0) and follow-up data (T1), including a 
‘melancholic’ subtype (prevalence 80.2% (T0) and 62.2% (T1)), and an ‘atypical’ subtype (prevalence 
19.8% (T0) and 37.8% (T1)). The melancholic subtype was characterized by decreased appetite and 
weight and had a stability of 0.86. The atypical subtype was characterized by increased appetite and 
weight and had a stability of 0.93, although the discriminating power of different symptoms had 
decreased at T1. Mean age and education differed significantly between stable and transitioning 
subgroups, other characteristics did not differ between subgroups.
Limitations: Limited sample size might have hampered the analyses.
Conclusions: Subtypes of late-life depression are relatively stable, but symptoms of depression (like 
weight loss) seem to blur with symptoms of (patho)physiological aging. This underlines the clinical 
relevance of depression subtyping, but also the importance of further research into subtypes and 
the influence of aging. 
Keywords: latent transition analysis; late-life depression; depression subtypes; stability of depressive 
subtypes; atypical depression; melancholic depression
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Introduction
Late-life depression is a common disorder, with a prevalence ranging from 1-16% (Djernes, 
2006). Especially late-life depression is associated with a poorer course (Schaakxs et al., 
2018), and comes with a high disease burden for both patients (Gallo et al., 2007) and 
their caregivers (Scazufca et al., 2002). Better insight into the aetiology and treatment 
options is therefore of great importance. However, to date research is being hindered 
by the heterogeneity of depression (Lux and Kendler, 2010; Goldberg, 2011), since the 
diagnosis of major depressive disorder (MDD) does not reflect the wide array of possible 
depressive symptom combinations. A diagnosis of MDD is made if 5 out of 9 DSM criteria 
are met, and since several of these symptoms are opposites (e.g. weight gain or loss), 
two patients diagnosed with MDD could have zero symptoms overlapping. In addition, 
previous, longitudinal studies demonstrated low longitudinal stability of depression 
categories described in the Diagnostic and Statistical Manual of Mental Disorders (DSM) 
edition 5 (American Psychiatry Association, 2013) such as major depressive disorder, 
dysthymia, and subthreshold depression (Angst et al., 1997, 2000). Acknowledging this 
heterogeneity, the DSM 5 contains several specifiers such as depression with atypical 
or melancholic features, but these have not proved sufficient to predict prognosis and 
treatment response (Parker et al., 2010; Lojko and Rybakowski, 2017). 
A different approach to examine the heterogeneity of depression is through data-driven 
methods (Lubke and Muthén, 2005), such as latent class analysis (LCA). These techniques 
cluster patients based on their congregate of different depressive symptoms, without 
a pre-conceived hypothesis. Studies in younger adults using LCA identified an ‘atypical’ 
subtype characterized by increased sleep and appetite, and a ‘typical’ or ‘melancholic’ 
subtype characterized by decreased sleep and appetite, and the presence of psychomotor 
symptoms (Kendler et al., 1996; Sullivan et al., 1998, 2002; Lamers et al., 2010; Rodgers et 
al., 2013; Li et al., 2014). In addition, these empirically-derived subtypes and their most 
distinguishing symptoms as appetite and weight have been linked to distinct biological 
and genetic correlates, and different neural activity on functional MRI (Lamers et al., 2013; 
Milaneschi et al., 2017; Simmons et al., 2018). In older adults, earlier data-driven studies 
have found subtypes mainly based on severity, probably due to inclusion of persons 
without a formal diagnosis of depression (Hybels et al., 2009, 2013; Lee et al., 2012; 
Mezuk and Kendler, 2012). Furthermore, not all of these studies distinguished between 
increase and decrease of sleep, appetite, weight and psychomotor symptoms, while these 
distinctions appeared to be crucial in identifying subtypes of depression in both younger 
(Lamers et al., 2010; Alexandrino et al., 2013; Rodgers et al., 2013). We have performed an 
LCA on older depressed adults taking this symptom distinction into account, and have 
found an atypical, melancholic, and moderately severe subtype (Veltman et al., 2017), 
similar to the aforementioned studies in younger adults. To further examine the validity 
and clinical usefulness of these subtypes, insight is needed into the stability and the 
potential transition rate of subjects across subtypes over time.
Latent transition analysis (LTA) is a data-driven method useful for examining the 
longitudinal stability and transition of subtypes of depression. In younger depressed 
adults, studies performing LTA have found a relatively high stability of subtypes (48-90%), 
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with the atypical subtype being the most stable (71-79%) (Lamers et al., 2012; Rodgers et 
al., 2014). In older depressed adults, so far one earlier LTA has been performed (Ni et al., 
2017). Their sample consisted of outpatients aged 60 to 96 years, and they demonstrated 
moderate stability of subtypes during 2-year follow-up (46-61%), with the highest stability 
in the subtype characterized by a moderate severity and a lack of positive affect. However, 
they did not differentiate between increasing and decreasing sleep, appetite, weight, 
and psychomotor symptoms, and as shown before, these symptoms are important in 
differentiating between subtypes of depression. 
The Netherlands Study on Depression in Older persons (NESDO) provides an excellent 
opportunity to examine the stability of late-life depression subtypes, with recognition of 
the importance of differentiation between increase and decrease in sleep, appetite and 
psychomotor symptoms. This paper is a follow-up of an earlier cross-sectional study that 
identified three subtypes of depression using latent class analysis, including an atypical, 
a melancholic, and a moderate subtype (Veltman et al., 2017). The atypical subtype 
was characterized by a high severity, and an increase in sleep, appetite and weight. The 
melancholic subtype was characterized by a high severity, but a decrease in sleep, appetite 
and weight. The moderate subtype was characterized by an overall lower prevalence of 
depressive symptoms. To examine the 2-year longitudinal stability of these subtypes, in 
this study we perform a latent transition analysis on persons derived from the NESDO-
cohort with a major depressive disorder (MDD) both at baseline and at 2-year follow-up. 
This study population differs from the population in Veltman et al. (2017) in chronicity, 
since a diagnosis of MDD on both time points was needed for inclusion. Nevertheless, 
considering the three identified subtypes in our previous study (Veltman et al., 2017), 
as well as the findings from LTA studies on younger adults identifying similar subtypes 
(Lamers et al., 2012; Rodgers et al., 2014), we hypothesize to find three subtypes among 
older depressed people using LTA, including a melancholic, atypical, and moderate 
subtype, with considerable stability during 2-year follow-up.
Methods
Study population
Data were derived from the baseline and 2-year follow-up measurements of the 
Netherlands Study of Depression in Older persons (NESDO), a longitudinal multi-site 
naturalistic cohort study, examining course and consequences of depression in older 
persons. The NESDO cohort (n=510) consists of persons aged 60-93 years, including 378 
persons with a depressive disorder in the previous 6 months at baseline, and 132 non-
depressed controls. Depressed older persons were recruited from both mental health care 
institutes and general practitioners in five regions in the Netherlands, in order to include 
persons with current late-life depression in various developmental and severity stages. 
Depression included a 6-month diagnosis of Major Depressive Disorder (MDD) (95%) 
and/ or 6 month dysthymic disorder (26.5%), or minor depression (two to four depressive 
symptoms lasting at least two weeks, 5.0%) according to DSM-IV-R criteria. Non-depressed 
older persons were recruited from general practices and were included when no lifetime 
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diagnosis of depression was present. Exclusion criteria were (suspected) dementia, and 
insufficient command of the Dutch language. The study design of NESDO is described in 
detail elsewhere (Comijs et al., 2011). 
For the present study, persons with a 6-month diagnosis of MDD at baseline (T0), and 
a 6-month diagnosis of MDD at 2-year follow-up (T1), were included. Persons with 
dysthymia or minor depression only were excluded. We chose to include only persons 
with a present diagnosis of MDD on both T0 and T1 because we specifically wanted to 
examine the longitudinal stability of depression subtypes.
Symptoms of depression
Ten depressive symptoms were used as indicator variables in the LCA analyses in order to 
identify depression subtypes. Nine depression key symptoms of the DSM-IV were based 
on the Dutch version of the Composite International Diagnostic Interview (CIDI) lifetime 
version 2.1, (World Health Organization, 1997; Andrews and Peters 1998) which were used 
to diagnose depressive and anxiety disorders according to DSM-IV criteria and conducted 
by specially trained clinical research staff. Changes in appetite and weight were used as 
two separate variables. All items were coded as ‘not present’ or ‘present’, except for the 
items regarding changes in appetite, weight, sleep and psychomotor disturbance. Here 
we created four categories, so for example for weight the categories were: absence of 
weight changes, weight loss, weight gain, and both gain and loss. 
Covariates
Several socio-demographic, clinical, psychosocial, and physical health indicators were 
used to characterize subtypes, equal to the covariates used in our baseline paper (Veltman 
et al., 2017) and mostly overlapping with similar studies in younger adults (Lamers et al., 
2012) to enable comparison. 
Socio-demographic variables, including age, gender and years of education, were collected 
during the baseline interview. Clinical characteristics such as age of onset of the depressive 
disorder and comorbid anxiety disorders were assessed by the CIDI. Severity of depressive 
symptoms was assessed with the of the 30-item Inventory of Depressive Symptomatology 
(IDS) (Rush et al., 1996). Further, we assessed several psychosocial variables. Overall daily 
functioning was measured with the World Health Organization Disability Assessment 
Schedule II (WHODAS) (Chwastiak and Von Korff, 2003); Buist-Bouwman et al., 2008). 
Apathy was measured using the Apathy Scale (Starkstein et al., 1992), and cognitive 
functioning by the Mini Mental State Examination (MMSE) (Folstein et al., 1975). Physical 
health indicators were included. Respondents were asked whether they were currently 
smoking (yes/no). In addition, their alcohol intake was calculated as number of drinks per 
week. Pain was measured using a count of pain locations (range 0-7) listed in the Chronic 
Graded Pain scale (Von Korff et al., 1992). The presence of metabolic syndrome (yes/no) 
was measured. Cut-off values for metabolic syndrome were based on the adjusted Adult 
Treatment Panel (ATP III) criteria (Expert panel, 2001), including waist circumference ≥88 
cm, triglycerides ≥150 mg/dl, HDL-cholesterol < 50mg/dl, systolic blood pressure ≥ 130 
mmHg or diastolic blood pressure ≥ 85 mmHg or use of anti-hypertensive drugs, fasting 
blood glucose ≥100 mg/dl or use of a hypoglycemic drug. Persons scoring positive on ≥3 
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criteria were considered to have a metabolic syndrome. Diabetes was defined as fasting 
plasma glucose level ≥ 7.0 mmol/l. Objective and standardized assessments of height and 
weight were performed. Body mass index (BMI) was calculated as kilograms divided by 
meter squared and categorized as underweight-normal (BMI<25), overweight (25≤BMI<30) 
and obese (BMI≥30). The number of chronic diseases, presence of cardiovascular disease 
(assessed by self-report supported by appropriate medication use (see Vogelzangs et 
al. (2010) for a detailed description), the presence of diabetes (based on fasting plasma 
glucose level ≥ 7.0 mmol/l or use of anti-diabetic medication [ATC-code A10] (WHO 2007)) 
was determined. Muscle weakness as an indicator of frailty was measured with a hand-
held dynamometer. This was considered present if persons scored below the cut off score 
after their performance was stratified by gender and BMI, according to Fried et al. (2001).
Outline of analyses
First, latent class analyses, using 10 CIDI-items as indicator variables, were performed 
at T0 and T1 separately. The conditional probability of occurrence of each depressive 
symptom, given class membership was examined using Cramer’s V. After identification of 
classes, latent transition analysis was performed, to examine the stability of the identified 
classes. Characteristics of all classes were examined. In univariate analyses, repeated 
measurement T-tests were used for normally distributed variables, McNemar tests for 
dichotomous variables, and Wilcoxon paired rank tests for non-parametric variables. 
In multivariable analyses, the two stable subtypes were compared, and analyses were 
corrected for variables that significantly changed the bivariate associations, when added 
separately (change odd’s ratio >10%).
Latent Class Analyses
To determine and identify subtypes of depressive disorders, we performed Latent Class 
Analysis (LCA). Free from any a priori assumptions about the number and characterization 
of subtypes, data-driven techniques such as LCA cluster persons into unobserved (‘latent’) 
classes, based on their values on several observed variables. Analysis starts with one 
class, suggesting one class fitting for all persons. Then, iteratively, one class is added to 
the model, and the best fitting number of classes is determined on the basis of several 
statistical indicators and interpretability. The LCAs were conducted using Mplus version 5 
(Muthén and Muthén, 2007).
To determine which model best fitted the data, we examined the sample size adjusted 
BIC (ssaBIC), entropy (i.e., classification accuracy), the bootstrapped Lo-Mendell-Rubin 
likelihood ratio test (LMR) (number of bootstraps used = 1000), the bootstrapped 
likelihood ratio test (BLRT) and the proportion of respondents in each class. Lower 
ssaBIC values indicate better model fit (Nylund et al., 2007a). Entropy, as a measure of 
classification accuracy, is presented for models with more than one subtype. Values for 
entropy can range between 0 and 1 with values closer to 1 indicating greater accuracy. The 
Lo-Mendell-Rubin test (LMR) provides a p-value, which indicates whether the k-1 subtype 
model is rejected in favor of the k subtype model. Similar to the LMR test, a p-value below 
.05 for the bootstrapped likelihood ratio test (BLRT) indicates that the present model 
fits the data better than the model with one class less; a p-value exceeding .05 indicates 
that the model with one class less should be preferred (Nylund et al., 2007a). There is no 
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consensus yet as to which criterion best identifies the best fitting number of classes, but 
the BLRT seems to be superior to other model fit indices (Nylund et al., 2007a).Finally, we 
only accepted models in which all classes contained at least five percent of the sample. 
Latent transition analysis
Latent transition analysis is a longitudinal mixture model that explores change in latent 
classes of individuals over time. Latent class analysis on two time points is used as a 
measurement model in LTA, from which individual-level change among these classes over 
time is defined by the transition analyses (Nylund, 2007b). Depending on the outcome 
of the two separate latent class analyses performed for T0 and T1, the latent transition 
analysis was modelled according to Nylund (2007b). In case of an equal number of 
subtypes for both latent classes analyses, these subtypes were compared in order to see 
to what extent they were similar. The latent transition model, calculating the movement 
of subjects between subtypes across time points, was modelled with respect to the 
comparability of subtypes found on T0 and T1. First, the degree of similarity between 
subtypes was compared through loglikelihood tests. For this purpose, we examined the 
extent of (in)variance of the subtypes in different models: a model where all conditional 
probabilities of variables were constrained to be equal across time, a model where all 
conditional probabilities were estimated freely across time, and models in which all 
conditional probabilities started out as variant, and were gradually coded as invariant 
(testing for partial invariance). The higher the number of conditional probabilities that 
were invariant across time, the higher the similarity of identified classes over time. 
Results
The total sample consisted of 111 depressed older people, of whom 67% were females, 
with a mean age of 70.9 (SD ±7.7) years at baseline and a mean age of depression onset 
of 44.2 (SD ±20.1) years.
In Table 1, demographics of the total sample at baseline (T0) and 2-year follow-up (T1) 
are shown.
Severity significantly decreased over time (p<0.01), as did body mass index (p=0.01), while 
muscle weakness increased (p=0.04). 
Table 2 shows the model fit indices for 1 to 4 classes on both T0 and T1. The best fitting 
model for the analysis on both baseline and 2-year follow-up was the 2-class model, with a 
significant Lo-Mendell-Rubin test (LMR) (T0 p=0.01; T1 p<0.01), a significant bootstrapped 
likelihood ratio test (BLRT) (T0 p<0.01; T1 p=0.01), lowest BIC and highest entropy. There 
is no consensus yet as to which criterion best identifies the best fitting number of classes, 
but the BLRT seems to be superior to other model fit indices (Nylund et al., 2007a). From 
the 3-class model onwards, the BLRT was no longer significant, indicating that adding 
more than two classes to the model did not improve model fit. Classification accuracy was 
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high, with average posterior probabilities for subgroups ranging between 0.825 – 1.000 
(n=111, data not shown), further indicating a reasonable classification quality.
Table 3 shows the estimated symptom profile probabilities for the two-class model 
on both T0 and T1. Variables are dichotomous (present or not present), except for the 
variables appetite, weight, sleep, and psychomotor symptoms, which are nominally 
divided into four categories (increase, decrease, both, or no change). In both subtypes 
weight and appetite, and to a lesser extent sleep and psychomotor symptoms, are the 
main significantly differing symptoms between subtypes. The first subtype in both T0 and 
T1 shows an atypical symptom pattern, with the highest occurrence of both weight gain 
and increased appetite, and is therefore labeled ‘atypical’. The second subtype in both T0 
and T1 is characterized by a more typical or melancholic symptom pattern with symptoms 
such as weight loss and decreased appetite, and is therefore labeled ‘melancholic’. 
Although especially the ‘atypical’ label resembles a specific DSM diagnosis, we explicitly 
do not intend to refer to this DSM diagnosis. Rather, the label is chosen to facilitate 
comparisons with our previous data-driven study on older depressed adults (Veltman et 
al., 2017), and with earlier latent class and latent transition analyses in younger depressed 
adults (Lamers et al., 2012; Rodgers et al., 2014).
We then performed a latent transition analysis to examine the stability of these subtypes 
between T0 and T1. The best fitting model included appetite as invariant symptom, and 
all other symptoms as variant. Both subtypes showed high stability (atypical subtype 
N=15, stability =0.93; melancholic subtype N=62, stability=0.87). The estimated transition 
probability of melancholic to atypical (N=27) was 0.14, and of atypical to melancholic 
(N=7) was 0.07.
Table 4 shows the characteristics of the stable subjects and transitioning subjects. The 
group transitioning from atypical to melancholic has the lowest mean age, followed 
by the stable atypical subtype. The stable melancholic subtype has the lowest years of 
education. Prevalence of diabetes was lowest in the stable atypical group and highest 
in the group transitioning from atypical to melancholic. Further group differences in 
demographic characteristics did not reach significance. Multivariable comparison of the 
stable atypical and the stable melancholic subgroup showed no significant differences 
(data not shown). Due to low numbers in the transitioning groups (melancholic to atypical, 
N=27, and atypical to melancholic, N=7), power limited multivariable analyses across 
all four groups. Next, multivariable comparison of the stable subjects, including both 
atypical and melancholic subtypes (N=77), versus the transitioning subjects, including 
persons transitioning from melancholic towards atypical and vice versa (N=32), did not 
yield significant findings. 
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Discussion
In this study, data-driven subtypes of old age depression and their stability over two-year 
follow-up were examined. Both at baseline and 2-year follow-up, two depression subtypes 
were identified. The first, melancholic subtype was mainly characterized by a decrease 
in appetite and weight. The second, atypical subtype was predominantly characterized 
by an increase in appetite and weight. Both subtypes had high temporal stability, with 
a slightly higher stability for the atypical subtype. Whereas transition rates between 
subtypes were low, subjects were more likely to shift from the melancholic subtype to the 
atypical subtype than vice versa. The stable atypical subtype had a lower mean age and a 
lower age of onset than the stable melancholic subtype, but this difference disappeared in 
multivariable analyses. Diabetes was lowest in the stable atypical group and highest in the 
group transitioning from atypical to melancholic. Other demographic variables were not 
significantly correlated to subtypes, neither in univariate, nor in multivariable regression 
analyses. No variables predicting transitioning, as compared to stable class membership, 
were discovered in multivariable analyses.
In contrast to our hypothesis and our previously published LCA (Veltman et al., 2017), 
based on data derived from the same cohort (N=359), we now identified two subtypes 
(atypical and melancholic) instead of three. The previously identified moderate subtype is 
now absent, which may be caused by a decline in study population and thereby a decrease 
in power. Since we specifically wanted to examine the longitudinal stability of depression 
subtypes, persons were only eligible for inclusion in the current study if they fulfilled 
DSM-criteria for MDD both at baseline and 2-year follow-up. Hence, a study population 
of chronic or recurrent MDD was selected, whereas in the former study (Veltman et al., 
2017) persons with non-chronic MDD were also included. Since chronic depression has 
been associated with higher depression severity (Reisinger Walker and Druss, 2015), this 
selection procedure may have resulted in a study sample with higher mean depression 
severity, and hence, the absence of a moderately severe subtype. Severity scores of the 
different cohorts indeed reveal a higher severity in the current study towards, with an IDS 
sum score of 34.9 (SD ± 13.1) in the present study and of 30.5 (SD ± 13.0) in our previous 
LCA study. In post-hoc analyses, we further explored the characteristics of the subjects 
that were included in our earlier LCA (Veltman et al., 2017), but not in our current LTA. 
These were subjects with either missing data on T0, or with MDD on T0 but not on T1 
(N=248). First, we found that participants in the current study were equally selected with 
respect to original subtypes (p=0.12); persons from all three LCA-derived classes were 
equally selected for inclusion in the current study. This suggests that the absence of a 
moderate severe subtype might be (partly) caused by a relatively small sample (N= 111), 
with less power for complex modelling. Furthermore, included subjects had a higher MDD 
severity on T0 (p=0.02) compared to excluded subjects. Of the 248 excluded subjects, 
64.1% (N=159) did not reach the criteria for MDD, and 35.9% (N=89) had dropped out. 
Reasons for drop-out were dropout due to unknown reasons between T0 and T1 (8.0%, 
N=20), refusal to participate at T1 (5.2%, N=13), not eligible due to physical or mental 
reasons (16.5%, N=41), no contact could be made (2.0%, N=5), or passing away (4.0%, 
N=10).
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Next, the symptom profiles of the identified atypical and melancholic subgroup in both 
T0 and T1, and their high temporal stabilities correspond to earlier studies on younger 
depressed adults (Lamers et al., 2012; Rodgers et al., 2014). In line with studies on younger 
adults, the atypical subtype was characterized by increased appetite and weight, and the 
melancholic subtype by decreased appetite and weight. In the current study however, 
the difference in appetite and weight symptoms between both subtypes was smaller at 
T1 as compared to T0. The reduced item discriminating power and very small number 
of invariable symptoms (1 out of 10) in the LTA model might imply that the nature of 
the atypical and melancholic subtypes is not completely stable over time. This might be 
because old age and aging are often associated with diminishing physical health (e.g. 
weight loss and muscle weakness) and somatic comorbidity, especially in depressed older 
persons (Holvast et al., 2017). These (patho)physiological processes might influence the 
presentation of late-life depression, and decrease the distinguishing power of symptoms 
such as appetite and weight over time. This hypothesis is supported by our finding that 
BMI and muscle strength significantly decreased during 2-year follow-up (see Table 1). 
This indicates the dwindling health of our subjects and may complicate the identification 
of depressive subtypes in an older population where depressive symptom presentation 
might be clouded by (patho)physiological aging. 
Nevertheless, taking these possible (patho)physiological alterations in aging into account 
by freeing conditional probabilities across time, the stability of the identified subtypes 
was high, and several characteristics were in line with earlier studies on subtypes of 
depression. Age was significantly lower in the stable atypical subgroup and in the 
subgroup transitioning from atypical to melancholic, compared to the stable melancholic 
subgroup and the subgroup transitioning from melancholic to atypical. In earlier studies 
among younger adults identifying a similar atypical subtype, age and age of depression 
onset were also lowest in the atypical subtype (Lamers et al., 2010; Veltman et al., 2017). In 
contrast with previous studies, however, in our study prevalence of metabolic syndrome 
and cardiovascular disease did not differ between the atypical and melancholic subtype, 
and prevalence of diabetes was lowest in our stable atypical subtype. It was previously 
demonstrated that chronic depression, in particular in older age, is associated with a 
wide array of somatic illnesses (Hegeman et al., 2017; Holvast et al., 2017). Likewise, in 
non-depressed older persons, prevalence of somatic illnesses is higher in older age. 
Hence, competing pathways, other than pathways associated with depression subtype, 
may result in onset of diabetes and cardiovascular disease in older persons. To conclude, 
we hypothesize that in our chronically depressed cohort of older persons, the lack of 
significant difference in metabolic and cardiovascular disturbances may rather reflect 
pathophysiological disturbances associated with either chronicity of depression or aging 
processes that are not linearly correlated with depression subtypes in late-life. In addition 
to this, the limited sample size and 2-year follow-up period might have been insufficient 
to find the true diversity in depression subtypes and their underlying pathophysiological 
pathways. Future research on the longitudinal stability of late-life depression subtypes 
with larger sample sizes and longer follow-up is warranted. 
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Strengths and limitations
The results of this study should be interpreted in the light of various strengths and 
limitations. A strength of this study is that it is the first latent transition analysis on older 
depressed persons taking both increase and decrease of weight, appetite, sleep, and 
psychomotor changes into account. This differentiation of symptoms has been especially 
distinguishing in earlier found data-driven subtypes, and it enables comparison with 
several studies on both younger and older adults. Furthermore, a wide selection of 
characteristics was examined. The limited sample size is an important limitation of the 
current study. Due to both selection of patients with chronic or recurrent MDD and to 
dropout due to morbidity and mortality in this older population, only a small number 
of the original population in our earlier study was included. This may decrease the 
reliability of our LTA, and may hamper our univariate and multivariable analyses. Another 
limitation is the possible violation of the local independence assumption (correlation 
between variables in a class is accounted for by the latent variable). This could occur if 
separate variables are included that measure different expressions of the same underlying 
symptom. 
Conclusion
To conclude, this is the first study that examined the temporal stability of data-driven 
subtypes of late-life depression taking into account both increase and decrease in sleep, 
appetite, weight, and psychomotor symptoms. An atypical and a melancholic subtype 
were found, both with a high stability over 2-year follow-up. Appetite and weight were 
main distinguishing symptoms, but their discriminating ability decreased over time. 
Since the overall cohort significantly declined in weight and physical health during 
2-year follow-up, the process of (patho)physiological aging might blur the differentiation 
of depression subtypes in older age. These findings stress the importance of taking the 
pathophysiological tangle of aging into account when searching for a better approach to 
diagnosis, treatment and prevention of late-life depression.
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Table 1. Characteristics of total sample at baseline (T0) and 2-year follow-up (T1) (N=111)
T0 T1
Overall
p-value (df)
Socio-demographics
Sex, female, % 66.7 * *
Age, mean (SD), y 70.7(7.6) * *
Education, mean (SD), y 10.5(3.8) * *
Clinical characteristics
Age of onset, mean (SD) y 43.8(19.7) * *
Severity (IDS), mean (SD) 34.9(13.1) 32.1(12.3) 0.01(110)1
Anxiety dx last year, % 46.8 37.8 0.132
Psychosocial
Functioning sx, mean (SD) 35.7(16.4) 37.4(16.1) 0.26(105)1
Apathy score, mean (SD) 18.3(5.1) 19.7(6.2) 0.09(108)1
MMSE score, median (IQR) 28.0(2.0) 28.0(2.0) 0.673
Physical health
Current smoking, % 27.0 # #
# alcohol/ week, median (IQR) 0.3(4.9) # #
Chronic pain grade, mean (SD) 2.3(1.3) 2.2(1.1) 0.53(100)1
Body mass index, median (IQR) 26.6(5.4) 26.3(6.2) 0.013
Cardiovascular disease, yes, % 26.1 27.0 1.002
Diabetes, yes, % 17.1 19.1 0.321
# chronic diseases, mean(SD) 2.9(1.9) 2.2(1.1) 0.80(109)1
Metabolic syndrome, yes, %
Muscle weakness, % 21.6 27.9 0.042
Tests used: 1=paired-samples t-test; 2=McNemar; 3=Wilcoxon paired rank test
* = no change over time/ no added value in mentioning
# = no data available on T1
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Objectives: In clinical practice, particularly melancholic depression benefits from electroconvulsive 
therapy (ECT), albeit research using DSM-derived melancholia is not conclusive. We compared 
clinical characteristics and ECT-outcome of melancholic and non-melancholic depression, here 
defined by psychomotor symptoms.
Methods: 110 depressed older inpatients treated with ECT were included in the Mood Disorders in 
Elderly treated with ECT (MODECT) study. The CORE was used for the assessment of psychomotor 
symptoms, with a score of ≥ 8 defining melancholic depression. Depression severity was measured 
before, during and after ECT. Characteristics were compared across melancholic and non-
melancholic patients. Regression analysis was used to assess the relation between psychomotor 
symptoms and remission/response, and survival analysis to examine the difference in time.
Results: Patients with melancholic depression had higher severity, lower cognitive and overall 
functioning and lower prevalence of cardiovascular disease. However, no significant relations were 
found between CORE scores and remission/response. Since psychotic symptoms are a positive 
predictor of ECT response and remission, we examined whether CORE score was a predictor of 
response in the non-psychotic group (N=49). In non-psychotic patients remission was 62%, and the 
association between CORE scores and remission almost reached significance (p=0.057). 
Discussion: Although melancholically and non-melancholically depressed patients differed 
significantly on several clinical characteristics, ECT-outcome did not differ. Analyses may be 
hampered by a high prevalence of psychotic features. In non-psychotic patients CORE scores 
neared significance as predictor of remission, suggesting CORE scores might be a distinguishing 
characteristic of melancholia in non-psychotic patients, and a clinical useful predictor of ECT 
response. 
Key words: late life depression; melancholic depression; psychomotor disturbances; predicting ECT 
response 
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Introduction
Unipolar depressive disorders are among the most common psychiatric disorders in our 
society. Prevalence rates in older patients range from 1-16%, depending on setting (e.g. 
private households to institutions) and criteria used[1]. Electroconvulsive therapy (ECT) 
has been proven to be very effective in (older) patients with depression[2-4], especially 
with psychotic[5] or pronounced psychomotor disturbances, including catatonia[6] 
. Considering its distinct phenomenology and treatment response, it is suggested that 
depression characterised by profound psychomotor disturbances may delineate a distinct 
mood disorder called ‘melancholic depression’[7]. 
The Diagnostic and Statistical Manual of Mental Disorder version IV Text Revision[8] and 
version 5[9] classifies melancholic depression as a depression subtype with psychomotor 
disturbances, decreased appetite and sleep, and diurnal symptomatology variation. 
In addition, it was recently demonstrated that patients with melancholic depression, 
either defined clinically[10] or data-driven[11,12] differed with respect to clinical 
characteristics and biological parameters from non-melancholic depression (e.g. higher 
mean age, higher age of onset, higher cortisol levels, and altered brain-connectivity in 
melancholic depression)[13-15] . However, previous studies using DSM-derived criteria 
for ‘melancholic depression’ failed to demonstrate favourable course trajectories during 
ECT[16] . A possible explanation is that a DSM diagnosis of melancholia does not require 
psychomotor disturbances, even though psychomotor symptoms are thought to be a 
core characteristic of melancholic depression and have also been identified as predictor 
of response to ECT [16]. Hence, the DSM criteria may lack content validity to identify 
melancholic depression[16] in depressed patients referred for ECT. 
An observational instrument better suited for identifying melancholic depression by 
thorough assessment of psychomotor disturbances is the CORE[17]. Indeed, one study 
demonstrated that higher CORE scores predicted ECT response[18]. However, further 
CORE-based research is limited, especially in older adults, and a recent meta-analysis 
could not confirm the predictive value of psychomotor symptoms for ECT-outcome, since 
too few studies examined psychomotor disturbances[19,20]. To conclude, to date there is 
no consensus on the predictive value of presence of psychomotor disturbances on ECT 
outcome. Further insight into this predictive value could help clinicians to better identify 
patients who will probably benefit from ECT, facilitating personalised medicine. 
In this study we examine differences in clinical characteristics and course trajectories 
during ECT across older depressed patients with and without psychomotor disturbances, 
defined by a cut-off CORE score of 8. We hypothesise that depressed patients with 
psychomotor disturbances (named ‘melancholic’) differ in several clinical characteristics 
from depressed patients without psychomotor disturbances (named non-melancholic), 
i.e. presence of psychotic symptoms, age, and depression severity[20], and cortisol 
measurements[21]. In addition, we hypothesise that melancholic depression is associated 
with a more favourable ECT-outcome compared to non-melancholic depression.
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Methods
Data were derived from the Mood Disorders in Elderly treated with Electro Convulsive 
Therapy (MODECT) study, a two-site longitudinal study including older in-patients (55 
years or older) with severe unipolar depression according to DSM-IV-TR criteria (American 
Psychiatric Association (APA), 2013), referred for ECT. Patients were recruited from tertiary 
psychiatric hospitals (GGZ inGeest, Amsterdam, the Netherlands and University Psychiatric 
Center, KU Leuven, Belgium). Patients with another major DSM-IV diagnosis or a major 
neurological illness (including Parkinson’s disease, stroke and dementia) were excluded, 
thus retaining a data set of 110 patients. For a detailed description of the MODECT-study, 
we refer to Dols et al[5]. For the current study, patients with missing data on baseline CORE 
and/or MADRS scores were excluded (n=17). Attrition analysis showed that excluded 
patients more often started with bilateral treatment (p = 0.002), used alcohol more often 
(p = 0.02), and had more often missing baseline data of both MMSE (p < 0.001) and Apathy 
scale (p = 0.03). Attrition was non-differential with regard to sociodemographics (age, sex 
and education), presence of psychotic symptoms, ECT indication, response, remission, 
and physical comorbidities.
Melancholic depression
Psychomotor disturbances were assessed with the Dutch version of the CORE[17,22], 
an observational instrument proved to be reliable and valid in assessing psychomotor 
symptoms in depression[22-26]. The CORE consists of eighteen items, subdivided into 
three different subscales: retardation, agitation and non-interaction. Each item is scored 
from 0-3, with 0 defined as the ‘absence or triviality’ of a feature. In accordance with 
guidelines[17], a total CORE score of ≥ 8 served as the cut-off for melancholic depression. 
Hence, patients were divided into melancholic (CORE ≥ 8) and non-melancholic (CORE < 
8) depressed patients.
Remission and response
The Dutch version of the MADRS was used to evaluate severity of depressive symptoms at 
baseline, weekly during ECT treatment, and the first week after treatment finished[27,28]. 
Remission was defined as a MADRS score ≤ 10 one week after ECT treatment finished. 
Response was defined as a decline in MADRS score of at least 50% one week after ECT 
treatment finished, compared to baseline MADRS score. 
Characteristics
Sociodemographic, clinical and physical health characteristics as well as biological 
parameters were examined at baseline. Sociodemographics included sex, age, and 
education level (low, middle or high), and were obtained by interview. Clinical characteristics 
included age of onset of depression, severity of psychomotor symptoms, depression 
severity, psychotic features, cognitive functioning, apathy, daily functioning, treatment 
resistance, and ECT-characteristics. Age of onset of depression was dichotomized into 
early versus late onset of depression (age of first depressive episode < 55 years) and was 
obtained by interview. Severity of psychomotor disturbances was assessed by total CORE-
scores. Depression severity was obtained by the MADRS[28]. Depression and the presence 
of psychotic features were based on the DSM-IVcriteria[8]. Cognitive functioning was 
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measured by the Mini Mental-State Examination (MMSE)[28]. Apathy was scored by the 
Apathy scale[30]. Daily functioning was assessed using the WHO Disability Assessment 
Schedule (WHO-DAS)[31,32]. The Antidepressant Treatment History Form (ATHF)[33] 
was used to assess previous antidepressant use for the current depressive episode, and 
treatment resistance. Through chart review we obtained use of psychotropic medication 
during ECT treatment (non-selective monoamine reuptake inhibitors (N06AA), selective 
serotonin reuptake inhibitors (N06AB), non-selective monoamine oxidase inhibitors 
(N06AF), monoamine oxidase A inhibitors (N06AG), other antidepressants (N06AX), lithium 
(N05AN01), haloperidol/ butyrophenone derivated antipsychotics (N05AD), atypical 
antipsychotics (N05AH) antiepileptics (N03A) ), number of ECT treatments, percentage 
of patients receiving unilateral ECT, the amount of patients switching from unilateral to 
bilateral ECT, and ECT indication (medication resistance or urgent).
For cortisol measurements, salivary cortisol samples were obtained at several time points: 
at time of awakening, 30, 45 and 60 minutes after awakening and at 10 pm (e.g. T1; 
07.00 am, T2; 07.30 am, T3; 07.45 am, T4; 08.00 am and T7; 22.00 pm). Patients received 
instructions concerning saliva sampling. Eating, drinking tea or coffee, and brushing 
teeth 15 minutes prior to sampling were not permitted. From the samples obtained 
within 2 hours after awakening (T1-T4), the area under the curve to the ground (AUCg) 
and to the increase (AUCi) was calculated, using Pruessner’s formula[34]. For a more 
detailed description of the procedures, we refer to Suijk et al[35]. Finally, physical health 
characteristics included smoking status, alcohol use and physical comorbidity. Current 
versus former/ no smoking was obtained through interview. Alcohol use was obtained 
through the Alcohol Use Disorders Identification test (AUDIT)[36]. Physical comorbidity 
was assessed in a semi-structured interview, including the presence of chronic obstructive 
pulmonary disease/ asthma/ emphysema, cardiovascular disease, myocardial infarction, 
hypertension, diabetes, cerebrovascular disease, arthrosis, (rheumatoid) arthritis, 
malignant neoplasms, migraine, thyroid disease, consequences of an accident, permanent 
disability due to surgery, Parkinson disease, other disease of the central nervous system, 
or other diseases. Furthermore, we separately examined the prevalence of cardiovascular 
disease, hypertension and diabetes within groups.
ECT procedure 
At least one week before starting ECT, patients were withdrawn from psychotropic 
medication, if clinical condition allowed. If this was deemed impossible, pharmacotherapy 
was kept stable 6 weeks before and during ECT. ECT therapy was administered twice 
weekly and conducted according to Dutch guidelines[37], starting right unilateral, unless 
there was an indication to start bilateral. All patients received brief-pulse ECT (0.5-1.0ms) 
with the Thymaton System IV, following dose titration protocol. A motor seizure of 20 
seconds or more was considered adequate, otherwise the dose was raised according 
to Dutch guidelines. Switching to bilateral ECT occurred in case of clinical worsening or 
no clinical improvement after 6 unilateral sessions. Clinical worsening was defined as an 
increase in MADRS scores, increased suicidality, weight loss, dehydration or increase of 
psychotic features. See also Dols et al[5] for a more detailed description of ECT procedure.
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Statistical analysis
Data were analysed using SPSS (Statistical Package of the Social Sciences, version 23, SPSS 
Inc., Chicago, IL). Statistical significance was defined as p < 0.05. Differences across groups 
for continuous variables were determined by independent t-tests for normally distributed 
data, and by Mann-Whitney tests for non-normally distributed data. Group differences for 
categorical variables were determined by chi-square tests. 
Logistic regression analyses were conducted to analyse the association between 
melancholic depression and both remission and response as outcome measures, 
compared to non-melancholic depression, using total CORE scores and the retardation, 
agitation, and non-interaction subscales. 
The analyses were adjusted for putative confounders, selected either on significant 
difference across melancholic and non-melancholic patients (p < .05), or based on 
previous findings[5,19].
Survival analyses (Cox regression) were performed in order to examine whether the 
melancholic and non-melancholic group differed in time (in days) to reach remission and 
response.
Results
Table 1 summarises demographic and clinical characteristics across melancholic and 
non-melancholic patients. The total population consisted of 89 patients, of whom 71 had 
melancholic depression. 66.7% were females, with a mean age of 73.0 years (SD=8.4). Sex 
and age did not differ significantly between groups. Patients with melancholic depression 
had higher baseline MADRS scores, lower MMSE scores, lower overall daily functioning, 
and lower prevalence of cardiovascular disease. No differences in cortisol measurements 
were found.
Next, the association between melancholic depression and ECT-outcome (remission 
and response) was examined (non-melancholic depression is reference) (see table 2: 
outcome defined as remission; and table 3: outcome defined as response). In model 1, 
the association between total CORE score and ECT-outcome was examined. In model 2, 
we additionally adjusted model 1 for demographics (age, sex and education). In model 
3, analyses were further adjusted for psychotic symptoms, MMSE and cardiovascular 
diseases. Finally, in model 4, analyses were adjusted for all previous variables and MADRS 
scores. Note that there is considerable correlation between CORE and MADRS scores 
(Spearman’s rho = 0.42, p < 0.001), reducing the reliability of model 4 due to possible 
multi-collinearity. Hence, these findings are presented in a separate model. In all models, 
melancholic depressionwas not associated with remission. Within melancholic patients, 
only psychotic symptoms were significantly associated with remission (model 4: OR: 3.61, 
CI: 1.02–12.71; table 2) and response (model 3: OR: 7.09, 95% CI: 1.41–35.73; model 4: OR: 
6.16, CI: 1.21–31.29; table 3). 
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Subsequently, using logistic regression analyses the association between CORE subscales 
(respectively agitation, retardation and non-interaction) and ECT-outcome was examined. 
The results are shown in table 4. Again, scores on the three CORE subscales were not 
significantly associated with either remission or response; and within melancholic 
depression only psychotic symptoms were significantly associated with response. 
Cox regression analysis was performed to examine potential differences in the time 
to achieve remission or response for the melancholic and non-melancholic patients. 
The survival distributions for two groups did not differ significantly (remission: 
OR(95%CI)=0.78(0.38-1.59), p=0.50, response: OR(95%CI)=0.95(0.51-1.77)).
With post-hoc sensitivity analyses, we examined whether characteristics and ECT 
outcome would differ if melancholic depression was defined as the median CORE score 
or higher (median CORE = 14.0). Using a higher threshold may exclude mild psychomotor 
disturbances due to other causes than melancholia, like medication or essential tremor. We 
also examined whether the outcome would differ when using the CORE as a continuous 
measure. However, both approaches did not change the results. (data available upon 
request). Furthermore, we examined whether there was an interaction effect between 
total CORE score and psychotic symptoms, which was not the case (p=0.80). Lastly, since 
psychotic symptoms are a positive predictor of ECT response and remission, we examined 
whether CORE score was a predictor of response in the non-psychotic group (N=49). 
61% of non-psychotic subjects reached remission. For response, we found no significant 
difference (p=0.105), but the association between CORE score and remission nearly 
reached significance(p=0.057). 
Discussion
In this study, we examined differences in clinical characteristics and course trajectories 
during ECT in older patients with melancholic depression compared to non-melancholic 
depression. Patients with melancholic depression, as defined by a cut-off CORE score of 8, 
had a higher depression severity, a lower MMSE score, lower overall daily functioning, and 
were less likely to have cardiovascular disease. Contrary to our hypothesis, response and 
remission rates did not differ between the two groups.
Previous findings suggested that melancholic depression has distinct 
characteristics[11,12,14] and a favourable ECT outcome[17], which is partly in line with the 
finding that our melancholic group showed several different characteristics compared to 
the non-melancholic group. Earlier studies defined a data-driven subtype of melancholia, 
and in line with our findings, this group was characterised by a higher severity, lower overall 
functioning, and a lower prevalence of cardiovascular disease[12,38]. However, we found 
no group differences for both number of patients and time to reach response or remission 
after ECT. Only psychotic features predicted a better ECT outcome. Using median CORE 
score (14.0) as cut-off did not alter results. However, since the ratio of melancholic versus 
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non-melancholic patients was rather askew (non-melancholic 19.4% (N=18)), the lack of a 
correlation with ECT outcome could be due to underpowering.
Previous studies suggested that people suffering from melancholic depression, have on 
average a higher age and age of onset of depression[39-41], although not all studies could 
replicate this[42]. We found limited differences in characteristics between melancholic and 
non-melancholic patients, with no difference in age, nor age of onset. Unfortunately, we 
could not examine the impact of age of onset on a continuous scale due to dichotomization 
of the data, with a cut-off of 55 years. The equal distribution of gender among groups is 
in line with earlier research[43], as is the significantly higher depression severity in the 
melancholic group[42,44,45], and the lower prevalence of cardiovascular disease in the 
melancholic group[12]. In our population, no significant difference in cortisol measures 
was found. This is in contrast with previous studies based on DSM-criteria reporting 
higher cortisol levels in melancholic versus non-melancholic depression[11,46], and with 
Parker et al[7] who argued that biological changes, such as hypercortisolemia, are distinct 
features of melancholic depression. 
Next, we examined the impact of depression subtype on ECT outcome. In contrast 
to our hypothesis, response and remission did not differ significantly between both 
groups. Likewise, in multivariable regression analyses, melancholic depression was not 
associated with ECT-outcome, nor the CORE subscales, including agitation, retardation 
and non-interactiveness. An earlier study using the CORE demonstrated that higher CORE 
scores predict ECT response[18], as opposed to the non-predictive value of DSM-defined 
melancholia on ECT response[16]. These results have not been replicated yet as most 
studies to date did not use CORE measurement to define melancholic features, hampering 
comparisons. Psychotic features however did predict ECT outcome in our study within 
the melancholic group, in line with a recent meta-analysis, finding that psychotic features 
predict both response and remission in ECT treatment[20]. It is suggested that psychotic 
features are a symptom of a very severe (melancholic) depression rather than a distinct 
subtype[47]. In our study, post-hoc analyses showed a moderately high correlation 
between total CORE score and psychotic features (Spearman’s rho = 0.42). This matches 
findings of Parker et al[7], who hypothesised that psychotic features within depression 
are a specific feature of melancholia, and therefore maybe even more distinguishing 
than psychomotor disturbances. In post-hoc analyses, we found the association between 
total CORE scores and remission within the non-psychotic group almost reached 
significance (p=0.057). This fits Parker’s hypothesis, suggesting that CORE scores might be 
a distinguishing characteristic of melancholia, but that this effect has been ‘overruled’ in 
our study by the high prevalence of psychotic features in our sample. 
To summarise, melancholic and non-melancholic depression only differed on a limited 
number of characteristics and were not associated with ECT-outcome. A possible 
explanation for our non-significant findings could be the high mean age of our cohort. 
CORE scores are found to increase with age[14,48,49], although the CORE is validated in the 
older population, too [50]. It is possible that higher CORE scores in older patients might be 
explained by various underlying pathophysiological pathways, such as neurodegenerative 
or vascular factors, and are therefore not clinically distinguishable from true melancholic 
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psychomotor disturbances. However, presence of psychotic features did predict ECT 
response, which may be indicative of a severe melancholic depression and thus a stronger 
predictor of response than the CORE. 
The findings of this study should be interpreted in the context of the following strengths 
and limitations. Strengths of this study are the detailed observation of psychomotor 
disturbances, and the vast number of characteristics that were examined. However, 
selection bias may have hampered our findings. The number of non-melancholic patients 
was low (n = 18 (19.4%)), indicating a probable selection bias in ECT-referrals. Combined 
with a relatively small number of included participants (N=93) and a high response 
percentage, this study population may have been too homogenous to identify differences 
in outcome. In addition, it remains to be settled to what extent the CORE is a valid measure to 
assess psychomotor disturbances in older depressed patients. Psychomotor disturbances 
due to other clinical conditions, such as cerebral vascular damage, neurodegeneration, 
other somatic comorbidities or medication side effects , may artificially increase the CORE. 
Lastly, attrition differed with respect to type of ECT (more bilateral ECT), suggesting that 
attrition may differ with respect to severity and/or melancholic depression as well. 
Conclusion
Patients with melancholic depression (defined as a CORE score ≥ 8) had higher 
depression severity, lower cognitive and overall daily functioning, and lower prevalence 
of cardiovascular disease than patients with non-melancholic depression. Total CORE 
score did not predict ECT outcome, but psychotic features did, and were moderately 
correlated to CORE scores. This suggests that psychotic features in combination with 
psychomotor disturbances may better characterize melancholic depression in older 
patients than psychomotor disturbances or psychotic features alone. Considering the 
significant correlation of CORE score with depression severity, our findings suggest that 
in this specific, rather homogeneous, sample of severely depressed in-patients, CORE-
measurements may only have any additional value for prediction of treatment outcome in 
non-psychotic patients. However, replication studies are required to confirm our findings.
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Table 1. Baseline characteristics with melancholy defined as CORE >=8 (N=89)
Total 
sample
Non-
melancholic Melancholic
Χ2, F, (df), 
overall P-value
Prevalence 89 (100%) 18(19.4%) 71(80.6%)
Sociodemographics
Sex, female, % 66.7 66.7 66.7 <.001(1), 1.001
Age, mean (SD), years 73.0(8.4) 71.8(9.8) 73.3(8.1) 0.69(91), 0.492
Education level, % 2.27(2), 0.321
Low 15.9 11.8 16.9
Middle 57.3 47.1 60.6
High 26.8 41.2 23.1
Clinical characteristics
Age onset <55 years, % 54.8 50.0 56.0 0.21(2), 0.791
CORE sumscore, median (IQR) 14.0(13.0) 5.0(3.0) 16.0(10.0) <.001(-6.57), <.0013
MADRS sumscore, mean (SD) 33.7(8.7) 27.4(10.0) 35.2(7.7) -3.62(91), <.0012
Psychotic features, % 47.3 50.0 46.7 0.07(1), 0.802
MMSE sumscore, median (IQR) 26.0(6.0) 28.0(5.0) 25.0(7.0) 419.00(-2.03), 0.043
Apathy, mean (SD) 24.8(7.2) 22.7(7.6) 25.3(7.1) -1.31(75), 0.202
WHO-DAS functioning, mean (SD) 43.6(15.0) 37.2(11.5) 45.6(15.4) -2.01(65), 0.052
No. antidepressant trials, median 
(IQR) 2.0(2.0) 2.0(1.0) 2.0(2.0) 3.26(5), 0.663
Max. resistance score, median (IQR) 3.0(2.0) 2.5(3.0) 3.0(2.0) 5.32(4), 0.263
Medication use during ECT, % 39.8 27.8 42.7 1.34(1), 0.251
Electroconvulsive therapy
No. ECT treatments, median (IQR) 11.0(7.0) 10.5(8.0) 12.0(7.0) 562(-1.10), 0.273
Start unilateral, % 96.8 94.4 97.3 0.39(1), 0.531
Switch unilateral to bilateral, % 31.2 38.9 29.3 11.98(2), <0.011
ECT indication 0.97(1), 0.321
Life threatening symptoms, % 25.8 16.7 28.0
Pharmacotherapy resistance, % 62.4 66.7 61.3
Other, % 11.8 15.7 10.7
Response after ECT, % 77.4 72.2 78.7 0.35(1), 0.561
Remission after ECT, % 68.8 55.6 72.0 1.83(1), 0.181
Cortisol measurements
AUCg, median (IQR) 6.9(4.6) 6.7(5.5) 7.4(5.2) 162(-1.69), 0.093
AUCi, median (QR) 5.9(4.6) 5.7(4.9) 6.4(4.9) 163(-1.67), 0.093
Evening cortisol, median (IQR) 3.2(2.2) 2.6(0.9) 3.5(2.2) 167.5(-1.76), 0.083
Physical health
Current smoking, % 25.6 29.4 24.6 1.16(2), 0.561
Alcohol use, % 29.9 43.8 26.8 1.80(1), 0.181
Alcohol units/ week, median (IQR) 0.0(1.0) 0.0(6.0) 0.0(1.0) 452.50(-1.57), 0.123
No. physical comorbidities, median 
(IQR) 1.0(2.0) 2.0(2.0) 1.0(1.0) 6.54(5), 0.263
Cardiovascular disease, % 23.7 50.0 17.3 8.58(1), 0.0031
Hypertension, % 30.1 27.8 30.7 0.06(1), 0.811
Diabetes, % 7.5 0.0 9.33 1.62(1), 0.181
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Table 2. Logistic regression analysis of remission for total CORE score
Variable
Model 1
OR (95%CI)
Model 2
OR (95%CI)
Model 3
OR (95%CI)
Model 4
OR (95%CI)
Total CORE score 1.04 (0.98–1.09) 1.02 (0.96–1.09) 1.05 (0.97–1.14) 1.07 (0.98–1.16)
Sex (female) - 0.47 (0.14–1.57) 0.41 (0.11–1.56) 0.40 (0.11–1.54)
Age - 1.02 (0.96–1.09) 1.04 (0.97–1.11) 1.04 (0.97–1.11)
Education, low (high=ref )
Education, middle 
(high=ref )
- 1.38 (0.29–6.39)3.01 (0.87–10.46)
2.37 (0.41–13.72)
4.05 (0.98–16.69)
2.45 (0.41–14.72)
3.77 (0.89–15.87)
Psychotic symptoms - - 3.16 (0.95–10.48) 3.61 (1.02–12.71)
MMSE - - 1.13 (0.98–1.31) 1.14 (0.98–1.32)
Cardiovascular disease - - 0.61 (0.17–2.19) 0.57 (0.16–2.07)
MADRS - - - 0.97 (0.89–1.05)
* Model 2 adjusted for demographics. ** Model 3 adjusted for demographics, psychotic symptoms, MMSE 
and cardiovascular diseases. *** Model 4 adjusted for variables in model 3, as well as MADRS score.
Table 3. Logistic regression analysis of response for total CORE score
Variable
Model 1
OR (95%CI)
Model 2
OR (95%CI)
Model 3
OR (95%CI)
Model 4
OR (95%CI)
Total CORE score 1.02 (0.96–1.08) 1.02 (0.95–1.09) 1.04 (0.95–1.13) 1.02 (0.93–1.12)
Sex (female) - 0.70 (0.19–2.52) 0.67 (0.16–2.89) 0.69 (0.16–3.03)
Age - 0.70 (0.19–2.52) 0.67 (0.16–2.89) 0.69 (0.16–3.03)
Education, low (high=ref )
Education, middle 
(high=ref )
- 1.56 (0.28–8.78)2.58 (0.68–9.73)
2.56 (0.36–18.39)
3.28 (0.69–15.53)
2.45 (0.34–17.67)
3.66 (0.75–17.80)
Psychotic symptoms - - 7.09 (1.41–35.73) 6.16 (1.21–31.29)
MMSE - - 1.14 (0.95–1.37) 1.13 (0.94–1.35)
Cardiovascular disease - - 0.63 (0.15–2.59) 0.70 (0.16–2.85)
MADRS - - - 1.05 (0.96–1.13)
* Model 2 adjusted for demographics. ** Model 3 adjusted for demographics, psychotic symptoms, MMSE 
and cardiovascular diseases. *** Model 4 adjusted for variables in model 3, as well as MADRS score.
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Table 4. Logistic regression analysis of remission and response with CORE subscales
Variable
Model 1
OR (95%CI)
Model 2
OR (95%CI)
Model 3
OR (95%CI)
Model 4
OR (95%CI)
Outcome defined as remission
CORE agitation 1.09 (0.91–1.29) 1.13 (0.92–1.39) 1.11 (0.89–1.39) 1.13 (0.89–1.42)
CORE retardation 1.05 (0.94–1.17) 1.01 (0.89–1.14) 1.04 (0.91–1.20) 1.06 (0.91–1.23)
CORE non-interaction 1.08 (0.96–1.21) 1.06 (0.93–1.21) 1.14 (0.96–1.35) 1.16 (0.97–1.39)
Outcome defined as response
CORE agitation 1.03 (0.86–1.24) 1.05 (0.84–1.31) 1.01 (0.80–1.28) 0.98 (0.77–1.25)
CORE retardation 1.03 (0.91–1.16) 1.01 (0.89–1.16) 1.06 (0.91–1.24) 1.03 (0.86–1.21)
CORE non-interaction 1.06 (0.94–1.21) 1.06 (0.91–1.23) 1.10 (0.91–1.34) 1.07 (0.88–1.31)
* Model 2 adjusted for demographics. ** Model 3 adjusted for demographics, psychotic symptoms, MMSE 
and cardiovascular diseases. *** Model 4 adjusted for variables in model 3, as well as MADRS score.
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Introduction: Electro Convulsive Therapy (ECT) is an important and effective treatment for 
depression. However, research on course trajectories of depressive symptoms during ECT is limited. 
Insight into putative differences in speed of response of depressive symptom dimensions may 
enable clinicians to optimally inform patients and their relatives. Therefore, we aim to examine 
course trajectories of depressive symptom dimensions in depressed older persons during ECT.
Methods: Data were derived from the Mood Disorders in Elderly treated with Electro Convulsive 
Therapy (MODECT) study, including 110 persons, aged 55 years or older, with a current diagnosis 
of major depressive disorder and referred for ECT. Exploratory factor analysis was used to identify 
symptom dimensions, using the ten depression items of the Montgomery-Asberg Depression 
Rating Scale (MADRS). Differences in course trajectories of symptom dimension during two weeks 
were examined by multilevel analyses. 
Results: Three symptom dimensions were identified: a ‘mood’, ‘melancholic’ and ‘suicidal’ dimension. 
‘Mood’ showed a significantly greater severity decline as compared to ‘melancholic’ and ‘suicidal’ 
at one-week follow-up. At two–week follow-up, both ‘mood’ and ‘melancholic’ demonstrated a 
significantly greater decline as compared to ‘suicidal’. However, since scores on the suicidality item 
of the MADRS were already lower at baseline compared to the other items, a floor effect cannot be 
ruled out.
Discussion: All symptom dimensions of depression showed a rapid response to ECT. Our findings 
did not support the general assumption that suicidal symptoms may be the first to improve. 
However, a floor effect on the suicidality item cannot be ruled out. 
Key words: course trajectories; factor analysis; major depressive disorder; late-life depression
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Introduction
Depressive disorders among older persons are highly common and frequently of a chronic 
nature. They cause a high burden for both patients [1] and their caregivers [2], with high 
societal costs [3,4]. Considering this great personal and societal impact, adequate treatment 
is of paramount importance. In addition to pharmacotherapy, electroconvulsive therapy 
(ECT) is an important treatment option for severe depressive disorders in older persons. 
It was demonstrated that older age is a positive predictor for ECT outcome [5,6], with 
remission rates from 73-90% in patients over 65 years of age [7,8]. In addition, the speed 
of remission is high [9,10], and significantly higher for ECT compared to pharmacotherapy 
[11]. 
When treating depression, not all symptoms resolve at the same pace or to the same 
magnitude [12-14]. Both pharmacotherapy and psychotherapy are known to ameliorate 
not all symptoms to the same extent [15,16], and, on average, remission occurs after 
several weeks to months. On the other hand, studies on ECT in both depressed older 
and younger adults have found that depressive symptoms show a very rapid response 
to ECT [9,10], and within younger adults response has been found especially rapid for 
psychomotor symptoms, such as inhibition, agitation, or inner tension [17-19]. In a recent 
study on early remission in ECT, the early remitters [requiring four or less ECT sessions, 
accounting for 14% of the study population] had a significantly higher age than the other 
subjects [20]. However, insight into response trajectories of different symptom dimension 
within depressed older persons is lacking. 
In order to gain a better insight into dimensions of depressive symptoms and their course 
trajectories during ECT in depressed older persons, we explored the speed of response of 
different depressive symptom dimensions in an elderly cohort receiving ECT. 
Materials and Methods
Study population
Data were derived from the Mood Disorders in Elderly treated with Electro Convulsive 
Therapy (MODECT) study, a two-site longitudinal study including older in-patients (55 
years or older) with severe unipolar depression according to criteria of the Diagnostic 
and Statistical Manual of Mental Disorders-Fourth Edition, Text Revision (DSM-IV-TR) [21], 
referred for ECT. Patients were recruited from tertiary psychiatric hospitals (GGZ inGeest, 
Amsterdam, the Netherlands and University Psychiatric Center, KU Leuven, Belgium). 
Patients with another major DSM-IV diagnosis or major neurological illness (including 
Parkinson’s disease, stroke and dementia) were excluded, thus retaining a data set of 110 
persons. Diagnosis was made at admittance to the ward by a psychiatrist and confirmed 
by the Mini International Neuropsychiatric Interview (MINI) 5.0.0, Dutch version [22]. 
The study protocol of MODECT has been approved centrally by the Ethical Review Board 
of the VU University Medical Center, Amsterdam, the Netherlands and subsequently by 
the ethical review board of the Leuven University, Leuven, Belgium. Before participating 
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in the study, all patients were provided with oral and written information. Written 
informed consent was obtained from all patients or - in case of inability consent- a legal 
representative. For a detailed description of the MODECT-study, we refer to Dols et al. [23]. 
Depressive symptoms
Depressive symptoms were measured by the Dutch version of the 10-item MADRS 
(Montgomery Åsberg Depression Rating Scale [24,25], a validated questionnaire for 
investigating ten symptoms of major depressive disorder (MDD), including apparent 
sadness, reported sadness, inner tension, reduced sleep, reduced appetite, concentration 
difficulties, lassitude, anhedonia, pessimistic thoughts and suicidal thoughts. For each 
item, a minimum of 0 points and a maximum of 6 points can be scored, according to 
symptom intensity. The cumulative score of the MADRS can be used as an indicator for 
the severity of a depression. In MODECT, MADRS was assessed at baseline (prior to ECT), 
and weekly during ECT by raters trained to administer the MADRS. For the current study 
baseline measurements and MADRS-scores during the first two weeks were used, since 
significant improvement to complete remission is often seen within two weeks already 
[11,20]. Patients were excluded if baseline MADRS, one-week follow-up, or two-week 
follow-up MADRS were missing (n=21). 
Attrition analysis showed that persons with missing MADRS-scores did not differ with 
respect to total MADRS score for baseline, week 1 and week 2, sex, age, and education 
from persons included in the study.
Characteristics
To characterize the study population and to enable comparison to other, similar studies, 
socio-demographics and clinical variables were examined. For a detailed description of 
measurement of characteristics and clinical variables, we refer to Dols et al. [23]. In short, 
socio-demographics included sex, age, and years of education. Clinical variables included 
early-onset of depression (<55 years) versus late-onset, assessed by interview. Number of 
prior depressive episodes and prevalence of psychotic features was assessed at baseline 
by the MINI and clinical interview. Current medication use was assessed by interview 
and double-checked by chart review. Previous antidepressant treatment and treatment 
resistance was scored with the Antidepressant Treatment History Form (ATHF) [26,27]. 
Depression severity was defined as the Montgomery-Åsberg Depression Rating Scale 
(MADRS) total score [24]. Number of somatic disorders was assessed in a semi-structured 
interview (see also Dols et al. [23]). Prevalence of cardiovascular disease was being defined 
as presence of hypertension or a history of myocardial infarct or stroke, and obtained 
through semi-structured interview. Current smoking was assessed by semi-structured 
interview. Alcohol use was measured by two questions based on the Alcohol Use Disorders 
Identification Test (AUDIT) [28] on frequency and amount of alcohol consumption.
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ECT-procedures
A course of twice weekly ECT along Dutch standards was given to all patients [29,30]. A 
course started with right unilateral stimuli. For ECT the Thymatron System IV (Somatics, 
LLC, Lake Bluff, IL, USA) (maximum energy 200%, 1008 mCoulomb) was used, according 
to a titration dosing protocol. All patients were treated with brief-pulse ECT (0.5-1.0 ms) 
twice a week. The stimulus intensity was determined by empirical dose titration at the 
first treatment, for right unilateral ECT six times the initial seizure threshold, and for 
bilateral ECT 1.5 times the initial seizure threshold. A motor seizure of less than 20 seconds 
or a seizure on electro-encephalogram (EEG)-recordings of less than 25 seconds was 
considered inadequate, upon which the dose was raised according to Dutch guidelines 
[29,30]. If the clinical condition worsened or if no clinical improvement was seen after 
six unilateral treatments, a switch to bilateral ECT was applied. ECT was continued until 
the patient reached a MADRS score of less than 10 at two consecutive ratings with a 
week interval. Additionally, if no further improvement was seen for two weeks, after a 
minimum of six unilateral and six bilateral sessions, ECT was stopped. Psychotropics such 
as benzodiazepines, antidepressants, and mood stabilizers were tapered off within two 
weeks before starting ECT, if clinically possible. Antipsychotics were allowed if clinically 
indicated. 
Statistical Analyses 
Since the MADRS consists of 10 items, examination of course trajectories of all items within 
depressed persons during 2-week follow-up would entail multiple comparisons, prone to 
type I error. Therefore, a factor analysis on baseline data incorporating the 10 items of the 
MADRS was conducted in order to reduce the number of items into a limited number of 
dimensions. Previously, several studies have addressed factor analysis of the MADRS, with 
factor structures ranging from two to four dimensions [31]. However, since the number 
of dimensions across studies differed, and since earlier studies used populations ranging 
from younger to older persons, we decided to perform an exploratory factor analysis (EFA) 
instead of a confirmatory factor analysis. Oblique rotation (promax) was used because 
the final dimensions were expected to be inter-correlated. Dimensions were extracted, 
based on preferential loading on one dimension, differences between loadings of at least 
0.20, and eigenvalues (>1.0) [32], observation of the scree plot, and interpretability of 
the dimensions. Next, course trajectories of the identified dimensions within depressed 
persons during one-week follow-up and two-week follow-up were compared using 
multivariate, multilevel analyses (multivariate with respect to both the different groups, 
and follow-up in time). For that purpose, depression dimensions were standardized over 
the entire measurement period, and multilevel analyses were performed on three levels. 
The dimensions were clustered within time points, and time points were clustered within 
patients. In multilevel analyses, time, different dimensions (both represented by two 
dummy variables), and the interaction between time and dimension were added to the 
model. The EFA was performed with SPSS version 21 (IBM Corp. Released 2012. IBM SPSS 
Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp) and the multilevel analyses 
were performed with MLwiN version 2.31 (Multilevel Modelling for Windows, Centre for 
Multilevel Modelling, University of Bristol).
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Results
The total sample consisted of 89 depressed older people, of whom 66.4% were females, 
with age ranging from 55 to 92 years and a mean age of 73.1 years (SD ± 8.3). Almost half 
of the sample (46.4%) had psychotic symptoms, and the mean number of prior depressive 
episodes was 3.7 (SD ± 3.3). MADRS scores at baseline ranged from 20 to 49, with a 
mean score of 32.6 (SD ± 7.6) and 78.7% had physical comorbidity, with a prevalence of 
cardiovascular disease of 43.8% (see also table 1).
Exploratory factor analysis identified three symptom dimensions (table 2), including 
a dimension consisting of apparent and reported sadness, concentration difficulties 
and anhedonia (MADRS items 1,2,6,8), henceforth called ‘mood’ dimension; a second 
dimension consisting of inner tension, reduced sleep, reduced appetite, lassitude, and 
pessimistic thoughts (MADRS items 3,4,5,7,9), henceforth called ‘melancholic’ dimension; 
and a third, separate dimension consisting of suicidality only (MADRS item 10), henceforth 
called ‘suicidality’ dimension. Factor loadings are presented in table 2.
Next, the course trajectories of the three symptom dimensions during the first two 
weeks of ECT were compared. Figure 1 shows the observed development over time in 
the three depression symptom dimensions. Within depressed persons, all symptom 
dimensions rapidly declined in severity after the start of ECT. Table 3 shows the results of 
the multivariate multilevel analyses. The mood dimension showed a significantly greater 
decline than the melancholic and suicidal dimension during the first week of ECT (i.e. the 
mood dimension decreased with 0.31 standard deviation units more than the melancholic 
dimension between baseline and follow-up). However, during two-week follow-up, the 
speed of response in the mood dimension did not differ significantly from the melancholic 
symptom dimension. Notably, although the decline of the suicidality dimension after 
one week was comparable to the decline of the melancholy dimension, after two weeks 
the suicidal dimension declined significantly less than the other two dimensions (i.e. the 
mood dimension decreased with 0.76 standard deviation units more than the suicidal 
dimension). Post-hoc analyses revealed that the median baseline score on the suicidality 
item was 2 (IQR=3), which was significantly lower than scores on most other MADRS items, 
and decreased to 1 (IQR=3) after one week (table 4).
Post-hoc, we also performed analyses of the decline over time for each individual MADRS 
item, to see whether this would generate new insights (supplement 1). All items (apart 
from lassitude and suicidality) declined significantly each week. In addition, the individual 
‘mood’ items showed greater coefficients of decline in week 1 as compared to week 2, 
except for reported sadness (coefficient= 0.88 in week 1 versus 0.89 in week 2); and all 
individual ‘melancholic’ items showed greater coefficients of decline in week 2 as compared 
to week 1 (results available upon request).This is in line with findings on speed of response 
of the aggregated domains, in which the ‘mood’ dimension shows a significantly higher 
speed of improvement as compared to ‘melancholic’ dimension in week 1. Improvement 
of lassitude seemed to lag behind, since there was only significant improvement in week 
2. Suicidality only showed significant improvement in week 1 (as compared to baseline). 
To conclude, findings are largely in line with findings on aggregated items.
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Discussion
The aim of our study was to identify dimensions of depressive symptoms within an older 
population, and to examine differences in speed of response of symptom dimensions 
within depressed older persons during the first two weeks of ECT. Three depressive 
symptom dimensions were identified, including a ‘mood’, ‘melancholic’ and ‘suicidal’ 
dimension. All dimensions showed rapid and significant improvement during the follow-
up, but the mood dimension demonstrated the highest speed of improvement during 
the first week of ECT, as compared to the ‘melancholic’ and ‘suicidal’ dimension. Likewise, 
both ‘mood’ and ‘melancholic’ dimensions improved at a significantly faster speed than 
the ‘suicidal’ dimension during two-week follow-up. 
Through EFA three dimensions were identified, similar to an earlier study by Parker et al. 
[33]. This study used MADRS-items in a population of 225 in- and outpatients aged 59 
years and older with major depressive disorder. They identified three distinct dimensions: 
a ‘dysphoric apathy/ retardation’ dimension, similar to our mood dimension, a ‘psychic 
anxiety’ dimension, and a dimension with vegetative symptoms. Our melancholic 
dimension corresponds to their psychic anxiety and vegetative dimension combined. 
However, whereas our EFA supports a separate suicidal dimension, Parker et al. [33] 
included suicidal symptoms in the vegetative dimension. Our finding of a distinct suicidal 
dimension can be explained by the fact that our study sample contains solely inpatients, 
while Parker et al. [33] used a mixture of in- and outpatients. Severely suicidal depressed 
older persons are more likely to be admitted and treated with ECT, which means that 
suicidality is probably a more prominent symptom in our inpatient sample compared to 
other studies including outpatients too, even though our population had a moderately 
high score on suicidality. Unfortunately, the study of Parker et al. [30] does not provide 
mean MADRS scores on the suicidal item, thereby hampering comparison. Other studies 
analyzing the factor structure of the MADRS also identified three dimensions, but great 
differences between theirs and our study population hampers comparisons with our 
study findings [34].
Our main study aim was to examine differences in course trajectories of the identified 
dimensions. All dimension improved significantly during the first two weeks, an advantage 
of ECT over other antidepressant treatments, since the latter usually requires several weeks 
to reach improvement [11], with studies also finding lagging on different symptoms or 
symptom dimensions [12-16]. We found that the suicidal dimension significantly lagged 
behind the mood dimension after the first week of ECT, but a floor effect causing that 
delay could not be ruled out. In post-hoc analyses, we examined the decline of each 
individual MADRS item in week 1 compared to baseline, and week 2 to week 1. We found 
that all items, apart from lassitude and suicidality, decline significantly each week, with 
a greater improvement of ‘mood’ items as compared to ‘melancholic’ items in week 1. To 
conclude, findings are largely in line with findings on aggregated items. Since the suicidal 
dimension was comprised of only one item, the responsiveness of this domain may be 
limited and a floor effect may be present.
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Since ECT is known to strongly enhance dopamine [35], the fast improvement of the mood 
dimension may be caused by the inclusion of anhedonia in this dimension, a symptom 
linked to disturbances in the dopamine pathways [36-38]. 
The findings of our study should be interpreted in the context of the following strengths 
and limitations. The design of this study provided the opportunity to examine course 
trajectories of depressive symptoms in detail, with weekly assessment of the MADRS. The 
MADRS however does not fully correspond to the DSM-IV-TR criteria for major depressive 
disorder [21]. The MADRS only addresses loss of sleep and weight/ appetite, whereas the 
DSM-IV-TR includes change of sleep and both gain and loss in weight/ appetite. Likewise 
the DSM-IV-TR criterion of psychomotor changes (both agitation and retardation) is not 
properly addressed by the MADRS. This may be of particular importance to our study, 
since psychomotor symptoms are considered to be a predictor of ECT response [19]. 
Earlier studies found a correlation between the MADRS item ‘inner tension’ and total CORE 
score (an instrument to assess psychomotor symptoms in depression), but being a single 
item measure, this item may not be sufficiently valid to measure the full construct of 
psychomotor disturbances [39]. 
Next, our results show that, although suicidality improved rapidly, the speed of response 
significantly lagged behind the mood dimension in week one, and behind both dimension 
in week two. Post-hoc analyses revealed that the median baseline score on the suicidality 
item was 2 (IQR=3), which was significantly lower than scores on most other MADRS items 
(table 4), and decreased to 1 (IQR=3) after one week. These findings suggest that a floor 
effect probably hampered any further decrease after week one, since the median baseline 
value was, of all items, closest to zero. 
To conclude, our findings show that ECT induces a rapid decline of all symptom dimensions 
in depressed older persons, with primacy of the mood dimension. Since anhedonia was 
included in this dimension, these findings suggest that ECT may rapidly restore dopamine-
related symptomatology. To what extent the (relatively) lagging behind of suicidal 
symptoms is related to clinometric properties of the MADRS (e.g. a floor effect) needs to 
be settled. Above all, since all depressive symptom dimensions already improved during 
the first week after ECT, this study underlines the potency of ECT to rapidly ameliorate 
depressive symptoms; a great benefit for clinical practice.
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Table 1. Characteristics of study population (N=89)
Sociodemographics
Sex, female, % 66.7
Age, mean (SD) 73.4(9.8)
Education level (in years), mean (SD) 6.4(2.7)
Clinical characteristics
Age onset, early, % 42.9
# prior depressive episodes, median (IQR) 3(2)
Psychotic features, % 46.4
Current medication use, % 39.8
ATHF (resistance sum score), mean(SD) 6.3(4.9)
MADRS, mean (SD) 32.6(7.6)
Physical health
Physical comorbidity, present, % 78.7
Cardiovascular disease, % 43.8
Smoking, % 18.2
Alcohol # daily, mean (SD) 2.2(0.7)
Table 2. Factor loadings of MADRS items after oblique rotation (N=89)
Dimension
Mood Melancholic Suicidality
MADRS items
Apparent sadness .275 -.047 .007
Reported sadness .212 .143 .070
Inner tension .161 .197 -.145
Reduced sleep -.093 .497 -.071
Reduced appetite .094 .165 .147
Concentration difficulties .274 .022 -.208
Lassitude .030 .403 -.213
Anhedonia .290 -.156 .203
Pessimistic thoughts -.036 .217 .198
Suicidality .008 -.014 .781
Grey marked cells indicate highest factor loading
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Table 3. Comparison of course of three symptom dimensions
Mood vs melancholic,
Score difference, p (95% CI)
Mood vs suicidal, score 
difference, p (95% CI)
Melancholic vs suicidal, 
score difference, p (95%CI)
Baseline – 1 week 
follow up 0.31, p=0.03(0.42-0.96) 0.35, p=0.01 (0.38-0.92) 0.05, p=0.73 (0.91-1.24)
Baseline – 2 week 
follow up 0.18, p=0.23(0.53-1.11) 0.76, p<0.01 (0.54-0.96) 0.55, p<0.01 (0.16-0.74)
Bold = significant
Table 4. Scores on separate MADRS items (N=89) (mean (SD); median (IQR))
Baseline After 1 week After 2 weeks
1. Apparent sadness 4.2(1.2); 4.0(1) 3.1(1.5); 3.0(2) 2.5(1.4); 3.0(1)
2. Reported sadness 4.4(1.4); 5.0(1) 3.5(1.4); 4.0(1) 2.7(1.5); 3.0(3)
3. Inner tension 3.7(1.2); 4.0(1) 3.0(1.3); 3.0(2) 2.3(1.3); 3.0(2)
4. Reduced sleep 2.7(1.6); 3.0(2) 2.3(1.7); 2.0(3) 1.6(1.5); 2.0(3)
5. Reduced appetite 2.8(1.8); 3.0(3) 2.5(1.8);2.5(3) 1.9(1.6); 2.0(3) 
6. Concentration difficulties 3.8(1.3); 4.0(2) 3.2(1.4); 4.0(2) 2.7(1.4); 3.0(2)
7. Lassitude 3.3(1.6); 4.0(3) 3.0(1.6); 3.0(2) 2.3(1.6); 2.0(3)
8. Inability to feel 3.8(1.4); 4.0(2) 2.8(1.3); 3.0(2) 2.3(1.5); 2.0(2)
9. Pessimistic thoughts 3.1(1.7); 3.0(2) 2.8(1.4); 3.0(2) 2.1(1.6); 2.0(2)
10. Suicidal thoughts 1.8(1.6); 2.0(3) 1.4(1.4); 1.0(3) 1.1(1.2); 1.0(2)
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Figure 1. Speed of response of symptom dimensions within depressed persons during first 2-weeks 
of ECT (1=baseline, 2=after one week, 3=after two weeks)
Figure legend: Speed of response of mood (blue line), melancholic (green line), and suicidal (yellow 
line) cluster, measured at baseline, one, and two weeks. Note that while all symptoms improve 
rapidly, the decline of the yellow line stalls after one week. This might be due to a floor effect, since 
baseline scores on the suicidal cluster were lower than both other clusters.
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Supplement 1. Coefficients and 95% CIs for separate MADRS items comparing scores at baseline, 
week 1 and week 2
Comparison of week 1 and week 2 
to baseline (=reference)
Comparison of week 2 
to week 1 (=reference)
MADRS items Week 1, coef (95%CI) Week 2, coef (95%CI) coef (95%CI)
1. Apparent sadness -1.07 (-1.35 – -0.80) -1.71 (-2.00 – -1.43) -0.64 (-0.93 – -0.36)
2. Reported sadness -0.88 (-1.18 – -0.58) -1.77 (-2.08 – -1.47) -0.89 (-1.20 – -0.58)
3. Inner tension -0.59 (-0.87 – -0.31) -1.32 (-1.61 – -1.04) -0.73 (-1.02 – -0.45)
4. Reduced sleep -0.45 (-0.77 – -0.14) -1.16 (-1.48 – -0.84) -0.71 (-1.03 – -0.38)
5. Reduced appetite -0.34 (-0.67 – -0.02) -0.85 (-1.18 – -0.52) -0.51 (-0.84 – -0.17)
6. Concentration difficulties -0.61 (-0.88 – -0.34) -1.14 (-1.14 – -0.86) -0.53 (-0.81 – -0.25)
7. Lassitude -0.30 (-0.61 – 0.01) -1.09 (-1.40 – -0.77) -0.78 (-1.10 – -0.46)
8. Anhedonia -0.94 (-1.21 – -0.66) -1.50 (-1.78 – -1.22) -0.56 (-0.85 – -0.27)
9. Pessimistic thoughts -0.34 (-0.64 – -0.04) -1.08 (-1.39 – -0.78) -0.74 (-1.05 – -0.43)
10. Suicidality -0.46 (-0.72 – -0.20) -0.71 (-0.97 – -0.45) -0.25 (-0.51 – 0.02)
Non-significant findings are underlined
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Summary
Late-life depression is a disease with a high burden on patients, their relatives and society 
(Gallo et al. 2007; Unützer et al. 2009). Improving our understanding of treatment and 
prognosis of this disease is of paramount importance. However, late-life depression is also 
a heterogeneous concept with many different forms of expression, hindering research 
and clinical practice. The DSM-5 distinguishes several subtypes (American Psychiatry 
Association 2013), such as depression with atypical features such as an increase in sleep 
and appetite, and with melancholic features such as a decrease in sleep and appetite, 
and psychomotor disturbances. However, research on underlying pathophysiology, and 
prognosis and treatment regarding different subtypes, remains inconclusive. Therefore, in 
this thesis we have tried to disentangle the heterogeneous concept of late-life depression, 
with a focus on melancholic depression and using data-driven techniques in order to 
identify putative subtypes of late-life depression. We further examined differences in 
clinical course and biological underpinnings of the identified subtypes. To determine 
clinical relevance of subtypes of depression, we investigated to what extent melancholic 
subtype, as characterized by psychomotor disturbances, would predict the outcome of 
electroconvulsive therapy (ECT). We also studied whether symptom clusters, as identified 
by factor analysis, show a differential speed of response to ECT. This may facilitate the 
identification of depression subtypes that may particularly benefit from ECT. 
Subtypes of depression and their stability over time
In Chapter 2, a latent class analysis (LCA) was performed on 359 older persons with major 
depressive disorder, with data derived from the Netherlands Study of Depression in Older 
People (NESDO). Ten CIDI-based depression items were used to identify subtypes. Subtypes 
were then characterized using various sociodemographic and clinical characteristics. 
Three classes were identified: a moderate-severe class (prevalence 46.5%), a severe 
melancholic class (prevalence 38.4%), and a severe atypical class (prevalence 15.0%). The 
strongest distinguishing features between the three classes were appetite and weight 
and, to a lesser extent, psychomotor symptoms and loss of interest. Compared with the 
melancholic class, the severe atypical class had the highest prevalence of females, the 
lowest mean age, the highest Body Mass Index (BMI), and the highest prevalence of both 
cardiovascular disease and metabolic syndrome. 
In Chapter 3, we examined to what extent these LCA-identified classes differ with respect 
to biological underpinnings. Previous studies have suggested that depression subtypes 
may differ in inflammation markers and hypothalamic-pituitary-adrenal axis functioning 
(Gold and Chrousos 2002; Stetler and Miller 2012; Lamers et al. 2013; Penninx et al. 2013), 
suggesting differences in underlying pathophysiological mechanisms. We examined 
differences in inflammatory markers including C-reactive protein (CRP), interleukin-6 (IL-
6), and neutrophil gelatinase-associated lipocalin (NGAL), as well as cortisol parameters. 
No differences in measures for inflammation and cortisol across subtypes were observed 
in uncorrected models, nor in models corrected for putative confounders.
In order to examine their clinical relevance, in Chapter 4, data-driven subtypes were 
examined with respect to their temporal stability over a follow-up period of two years. 
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Again, data from the NESDO study was used, this time including all subjects with a diagnosis 
of major depressive disorder for the past six months on both baseline and two-year follow-
up (n=111). Latent class analysis of depressive symptoms was performed at both time 
points, followed by a latent transition analysis to examine the stability of identified classes 
over time. Stability and transition rates between subtypes and characteristics of groups 
were then examined. Two subtypes were identified in both baseline (T0) and follow-up 
data (T1), including an atypical subtype (prevalence 19.8 (at T0) and 37.8% (at T1)) and a 
melancholic subtype with typical depressive symptoms (prevalence 80.2 (at T0) and 62.2% 
(at T1)). The atypical subtype had a stability of 0.93, and the melancholic subtype had a 
stability of 0.86, suggesting high temporal stability. No moderately severe subtype could 
be identified, in contrast to our study in Chapter 2 where a third subtype was identified, 
characterized by moderate depression severity.
Melancholic depression and electroconvulsive therapy
In Chapter 5, we examined whether melancholic features in late-life depression, 
characterized by profound psychomotor disturbances as measured by the CORE (Parker 
et al. 1995), had predictive value for ECT outcome. We included patients (n= 110) 
from the Mood Disorders in Elderly treated with ECT (MODECT) study. Characteristics 
were compared across melancholic and non-melancholic patients (i.e. a CORE score 
of respectively ≥ 8 or < 8). Furthermore the relation between psychomotor symptoms 
and remission/response, and the relation between psychomotor symptoms and time 
to remission/response, was examined. Patients with melancholic depression had higher 
severity, lower cognitive and overall functioning, and lower prevalence of cardiovascular 
disease. Notably, the latter characteristic was also found in the data-driven melancholic 
subtype in Chapter 2. However, no significant relations were found between CORE 
scores and remission/response. Since psychotic symptoms are a positive predictor of ECT 
response and remission (Van Diermen et al. 2018), and hence may subsequently overrule 
psychomotor symptoms as predictor of ECT-outcome, we examined whether CORE 
scores were predictive for response in the non-psychotic group (N=49). In non-psychotic 
patients, remission rate was 62%, and the association between CORE scores and remission 
almost reached significance (p=0.057). 
Finally, in Chapter 6, we examined whether ECT would ameliorate all depressive 
symptoms at the same speed. Differential speed of response of depressive symptoms may 
inform us on putative working mechanisms of ECT, and could facilitate the identification 
of depression subtypes that may particularly benefit from ECT. Hence, in Chapter 6, we 
examined whether different symptoms of depression improved at the same speed during 
the first two weeks of ECT. In order to avoid multiple comparisons, exploratory factor 
analysis was used to identify symptom dimensions, using the ten depression items of the 
Montgomery-Asberg Depression Rating Scale (MADRS). Differences in course trajectories 
of symptom dimensions during two weeks were examined by multilevel analyses. Three 
symptom dimensions were identified: a ‘mood’, ‘melancholic’ and ‘suicidal’ dimension. 
‘Mood’ showed a significantly greater decline in severity as compared to ‘melancholic’ and 
‘suicidal’ at one-week follow-up. At the two-week follow-up, both ‘mood’ and ‘melancholic’ 
demonstrated a significantly greater decline as compared to ‘suicidal’, but all dimensions 
showed a rapid and large decline of symptoms over the course of two weeks. 
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General discussion
In clinical practice, late-life depression has many different manifestations. This complicates 
diagnosing, treating, and predicting course for those suffering from depression. Treatment 
protocols for depression do not take this heterogeneity into account, because subtypes 
of depression, as currently specified in the DSM-5, are not yet so well-defined that specific 
treatment can be based on them. This may lead to a large delay in finding the right 
treatment, and to the risk that patients have to endure potentially harmful side effects 
from trying several kinds of medication. A first step in disentangling late-life depression is 
identifying meaningful subtypes, and we aimed to find these using latent class analysis. 
Although we identified three subtypes of late-life depression (Chapter 2-3) , including a 
severe atypical subtype, a severe melancholic subtype, and a moderately severe subtype, 
these did not correlate with distinctive biological disturbances, contrary to our hypothesis 
and to results in younger depressed people (Lamers et al. 2013). We think that associations 
between depression subtypes and biological markers, if present, may be obscured since 
currently used biological parameters such as CRP, IL-6 and NGAL, may also be involved 
in aging processes, other (somatic) disease processes, and polypharmacy. Nevertheless, 
the subtypes identified in Chapter 2 may be of value in disentangling depression, since 
they have a distinct symptom and characteristics profile. Especially in our study, the 
atypical subtype may represent a distinct subtype, characterized by a relatively young 
age and early onset of depression, a high prevalence of females, and a high prevalence 
of metabolic syndrome. This is in line with the results of latent class analyses on younger 
adults (Lamers et al. 2010; Rodgers et al. 2013), and with a study by Schaakxs et al. (2017), 
the latter studying a population of depressed persons aged 18-93 and finding that 
depression in younger persons was correlated with BMI. Notably, the atypical subtype 
was also identified in our latent transition analysis (Chapter 4), showing a high temporal 
stability. This suggests that atypical depression constitutes a specific depression subtype 
across the life-span. Further supporting this is the overlapping phenomenology of 
atypical depression in younger (Lamers et al. 2010; Rodgers et al. 2014; Li et al. 2014) and 
older adults (Chapter 3), the high temporal stability of the atypical subtype, which is in 
line with previous studies in younger adults (Lamers et al. 2012; Rodgers et al. 2014), and 
the findings on a genetic overlap with metabolic disturbances (Milaneschi et al. 2015). 
Likewise, in addition to an atypical depression subtype, we also identified a melancholic 
depression subtype (Chapter 2), as was previously found in studies on younger adults 
(Lamers et al. 2010; Alexandrino et al. 2013; Rodgers et al. 2014). Symptom profiles of 
the melancholic subtype in these different studies are largely similar, characterized by 
a decrease in appetite, weight and sleep, together with psychomotor disturbances and 
a high symptom severity, as well as similar characteristics such as a high prevalence of 
males and a low prevalence of metabolic syndrome. 
However, contrary to research in younger adults (Gold and Chrousos 2002; Stetler 
and Miller 2011; Lamers et al. 2013), the melancholic subtype in older adults was not 
associated with alterations in cortisol measures, as compared to the non-melancholic 
subtypes. Earlier (Chapter 2), we found that the melancholic subtype had a higher age 
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and higher age of depression onset, compared to the two other subtypes in our older 
population. In younger adults, however, melancholic subtype is not characterized by a 
higher age or age of onset (Lamers et al. 2010; Alexandrino et al. 2014). Considering these 
studies on younger adults and our findings, we hypothesize that this melancholic type 
of depression can develop during (early) adulthood, but seems to have a renewed influx 
of older patients in late life, causing the higher mean age of the melancholic subtype in 
late-life depression (Chapter 2). To what extent there is indeed a bimodal distribution of 
melancholic depression subtype, and to what extent these subtypes actually represent 
different etiological and pathophysiological pathways needs to be established.
Both the older people with a melancholic depression described in Chapter 2, and 
those in Chapter 5, who were not defined by data-driven subtyping but by a CORE 
score ≥ 8, had a very low prevalence of cardiovascular disease compared to the non-
melancholic depressed persons. This is remarkable since cardiovascular disease is often 
more prevalent in old age (Khan et al. 2017), and because one would expect a higher 
prevalence considering the worse overall health of depressed older persons (Grover et al. 
2017). Although cardiovascular disease and inflammation are intertwined with aging and 
therefore hard to tell apart, these findings show that it is important to examine the role of 
cardiovascular disease in two ways; both higher and lower prevalence may be associated 
with specific subtypes in depression. A possible explanation for this finding is that our 
relatively old groups with melancholic disease (mean age melancholic depression in 
NESDO 70.5 years ±7.1; mean age melancholic depression in MODECT 73.3 years ± 8.1) 
simply are survivors, and that persons with atypical depression may die younger because 
of comorbid cardiovascular diseases.
To summarize, whereas our findings are largely in line with findings in younger adults, the 
lack of associations between depression subtypes and various biomarkers in our older 
population is remarkable. This raises the question as to what extent other mechanisms in 
older age are involved, which may blur any underlying pathophysiological mechanism and 
affect the clinical picture. Ageing is a process that is associated with many homeostatic, 
metabolic and hormonal changes and disturbances (Aalami et al. 2003; Khan et al. 2017). 
It is extremely difficult to define where normal aging ends, and pathophysiology begins. 
One of the common processes present in aging is the elevation of blood inflammatory 
measures, for which the phrase ‘inflammageing’ has been coined (Ferrucci and Fabbri, 
2018) and which has been linked to an array of predisposing factors, ranging from genetic 
susceptibility to changes in the microbiome and central obesity (Monteiro et al. 2010). On 
the other hand, low-grade inflammation in aging can also lead to frailty (Soysal et al. 2016; 
Marcos – Pérez et al. 2018), a concept describing a state in which the physical condition 
of (older) patients has decreased to a critical minimum, and in which a relatively small 
disturbance of these systems can lead to the development of severe mental and physical 
problems (Collard and Oude Voshaar 2012). Further complicating matters is that frailty may 
also largely overlap with phenomenology of depression in older persons. These various 
endpoints (e.g. either obesity or frailty) of a common pathophysiological pathway, illustrate 
that the process of ageing is a complicated tangle of possible physiological disturbances. 
This could especially be true for our depressed population. Late-life depression is known 
to have a high prevalence of physical comorbidity and polypharmacy, even beyond the 
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increased rates of comorbid somatic diseases (Holvast et al. 2017), further complicating its 
pathophysiology and making it impossible to link biological disturbances to co-occurring 
psychopathology. For instance, elevated cortisol levels are both linked to depression in 
older persons (Belvederi Murri et al. 2014) and to aging itself (Larsson et al. 2009), making 
it increasingly difficult to determine the role of cortisol in late-life depression. However, 
understanding pathophysiology and risk factors of late-life depression are important for a 
better treatment and prevention, and ideas on how to approach this pathophysiological 
tangle are addressed below in ‘Future Directions for Clinical Research’. 
Subtypes and treatment response
Another way of trying to differentiate between types of depression is to examine differences 
in treatment response across subtypes. Psychomotor disturbances (PMD) might be a main 
feature of melancholic depression (Parker et al. 2010) and is thought to react especially 
well to ECT, which targets the dopaminergic networks (Nutt et al. 2006, 2008) likely 
underlying PMD and psychotic symptoms (Van Diermen et al. 2018; Heijnen et al. 2019). 
The CORE (Parker et al. 1995) is a clinical instrument that measures PMD in depression, 
and could help identify the melancholic subtype, defined by PMD, of depression (Parker 
et al. 2010). In Chapter 5, we have examined whether higher CORE scores may identify 
subtypes of depression with favourable ECT-outcome. However, CORE scores did not 
predict ECT outcome, whereas the presence of psychotic symptoms predicted a positive 
ECT outcome. Our cohort included a large number of persons with psychotic features 
(47.3%). Since we think that psychotic features are an even stronger predictor of ECT 
response, the possible predictive effect of PMD may have been overshadowed. 
Although one would expect that ECT mainly relieves symptoms specifically related to 
dopaminergic networks, in Chapter 6, we show that all depressive symptoms quickly 
improve with ECT, also those that are commonly related to disturbances in serotonergic 
and noradrenergic networks (Nutt et al. 2008). This underlines the necessity of further 
studies to distinguish those patients who will have a good response to ECT.
This thesis has tried from various angles to better understand late-life depression and 
to relate (pathophysiological) subtypes of depression with clinical implications. We think 
our studies have contributed to the understanding of late-life depression and its different 
appearances, but we have also shown the difficulties in understanding its pathophysiology, 
and how research in older adults demands a different approach from research in younger 
adults. It is generally accepted that in older people, little physiological changes can have 
an important and enduring impact. The key to understanding depression in late life 
might therefore not be studying changes in different physiological systems separately, 
but rather in a complex network of physiological systems. This could also be a reason for 
why the prognosis of late-life depression is generally poor (Comijs et al. 2015; Schaakxs 
et al. 2018). If a complex system changes, a new equilibrium will be the result of many 
little shifts and will probably be worse than before, especially in frail older persons in 
whom reserve capacity was already low. Viewing (patho)physiology as a complex network 
has implications for the research methods that should be used, and this will be further 
addressed below in ‘Future Directions for Clinical Research’.
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Methodological considerations
The findings of this thesis should be considered regarding various strengths and limitations. 
A major overall strength of this thesis is that we used different methods and different 
study populations of depressed older persons to gain more insight into the heterogeneity 
of late-life depression. The large study population and the longitudinal design of the 
NESDO study enabled us to apply data-driven methods and test the stability of subtypes 
over time, and to include several covariates. Furthermore, the design of the study being 
similar to the Netherlands Study on Depression and Anxiety (NESDA) (Penninx et al. 2008) 
in younger adults enabled us, to a certain extent, to compare results. The MODECT study 
allowed us to gain better insight into the course trajectories of ECT response, because of 
the thorough and frequent data collection with measurements on depressive symptoms 
every week during ECT.
Of course, the studies presented in this thesis also have methodological limitations. The 
NESDO cohort existed mainly of outpatients, and therefore our results might not be 
generalizable to the group of severe (hospitalized) patients. Furthermore, the results from 
Chapter 4 are only applicable to a specific subset of chronically depressed older persons, 
and it is unclear whether the persons included in Chapter 2, but not in Chapter 4, 
were either excluded due to remission of depression, the development of comorbid 
disorders like dementia which was also an exclusion criterion, or even due to a high 
mortality between baseline and two-year follow-up meetings (see also Jeuring et al. 
2018). Other longitudinal studies on the course of late-life depression show a worse 
prognosis compared to younger adults, with a more chronic course (Schaakxs et al. 2018). 
Therefore, a high remission percentage seems unlikely, and the dropout is probably 
partially caused by morbidity and mortality of our subjects. This means the subtypes and 
their longitudinal stability as found in Chapter 4 are mainly based on a population with 
a chronic depression but relatively mild comorbidity, which could have caused the lack in 
differences in characteristics between subtypes.
Despite the large sample size of NESDO, the cohort size may have still been too limited to 
facilitate research into subtle differences in especially biological parameters. In addition, 
for the LTA, since only persons with MDD both at baseline and two-year follow-up could 
be included, persons experiencing remission either spontaneous or due to treatment 
were excluded. This select inclusion was needed in order to find subtypes based on 
symptoms and not on severity, but it may have further limited power to detect differences 
on characteristics of the subtypes when examining stability and transition. It could also be 
that our subtypes were still too broad and heterogeneous. Especially since we hypothesize 
that both inflammation, ‘inflammageing’, and biological disturbances can lead to this final 
common pathway of developing atypical depression, the pathophysiology of our atypical 
subtype might still be too heterogeneous for biological research.
A possible limitation of the MODECT study that might have hampered our results, is the 
homogeneity of the population. The amount of psychomotor disturbances and a response 
percentage to ECT were very high, probably because people enrolled in the study were 
already selected for ECT. This complicated the distribution of our cohort into meaningful 
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subgroups in Chapter 5, and might have meant a fast and broad symptom decline in 
Chapter 6.
Clinical implications
In several chapters, and in line with research on younger adults, we have shown the 
putative linking of atypical depression to metabolic disturbances, and its high stability 
over time. Although the direction of this correlation between atypical depression and 
metabolic disturbances is still unknown (see also ‘Future directions for clinical research’), 
these results emphasize the importance of paying attention to metabolic syndrome in 
the doctor’s office. As argued above, the relationship is probably complex and related 
to many other processes taking place simultaneously, but we think that optimizing the 
physical condition of the patient will affect their psychological state in a positive way. 
Patients might especially benefit from measures to prevent inflammatory processes that 
could eventually lead to cardiovascular disease and metabolic disturbances.
Furthermore, our results stress the importance of considering ECT as a first treatment 
option in depression with psychotic features, especially in older persons since age is 
positively correlated with ECT response and all symptoms rapidly improve during ECT 
treatment in the first two weeks.
Future directions for clinical research
Late-life depression subtypes in different groups of patients
Our findings warrant replications in other populations, to see to which extent our 
subtypes are applicable to other populations. For instance, these analyses could be 
repeated in hospitalized older patients, who often have a more severe depression or 
factors barring them from being treated at home, like (somatic) comorbidity or a lesser 
support system. This could provide information on both the applicability of our subtypes 
to other populations, the role of depression severity on identifying subtypes, and the role 
of (severe) somatic comorbidity and social factors like loneliness.
Biological pathophysiology of depression subtypes
As discussed in the above paragraphs, the inflammatory measures currently used are not 
specific enough to distinguish depression from aging, warranting a different approach. A 
way to circumnavigate this problem might be to shift focus from blood tests to genetic 
profiles of subtypes of depression, since these do not change over time. Milaneschi et 
al. (2015) have already examined the genetic overlap between atypical depression and 
metabolic disturbances. It would be interesting to repeat this study in an older population 
with atypical depression, to see whether a comparable genetic profile to the younger 
population will be found or if other risk factors are important in developing atypical 
depression in later life.
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Melancholic depression has not been associated genetically (yet) to biological disturbances, 
but research suggests depression characterized by psychomotor disturbances, like 
melancholic depression, shows genetic overlap with bipolar disorder (Bellivier et al. 2013) 
and schizophrenia (Milaneschi et al. 2015). It would be interesting to examine whether 
this is also the case with our data-driven melancholic subtype. Furthermore, melancholic 
depression is often seen as a spectrum with catatonia and psychotic features at the far 
(severe) end (Taylor and Fink 2006; Parker et al. 2010) and it would be interesting to see 
whether patients suffering from catatonia and psychotic depression will indeed fit into 
our data-driven melancholic subtype. 
Another interesting approach would be to increase insight into depression as a final 
outcome of a cascade of events. As argued above, psychiatric diseases should be regarded 
as part of an intricate network of symptoms rather than a static syndrome. Symptoms 
cluster together and branch out to other both psychiatric and somatic diseases. 
Network analyses are a relatively new and promising methodology for the mapping and 
visualisation of disease complexity and connections between symptoms. Better insight 
into these networks and its hubs could provide new insights into (patho)physiological 
processes related to late-life depression, and give information about the sequence of how 
disturbances develop and symptoms emerge.
Predicting treatment response
Another clinical problem that could benefit from better understanding depression 
subtypes is how to apply a treatment algorithm, and predicting which patient will benefit 
from which treatment. ECT is highly effective in some people, but unless a patient presents 
with (life-threatening) psychotic features or catatonia in depression, it is the last option in 
the protocol for treating depression whereas waiting lists for ECT in the Netherlands can be 
long. Predicting who will benefit and who will not, will diminish delay for responders and 
will spare non-responders an invasive treatment. To better identify factors predicting ECT 
response, larger and more heterogeneous cohorts are needed, for instance also including 
bipolar disorder and outpatients. It would also be interesting to explore whether other 
‘dopaminergic symptoms’ like anhedonia, loss of motivation, and loss of interest have a 
predicting value in ECT response. Furthermore, increasing our knowledge about which 
patients will benefit from ECT will also help us to better understand the pathophysiology 
of depression, by studying structural, functional, and neurotransmitter-related changes 
ECT causes in the brain.
Another direction for future research is trying to find more adequate treatments for the 
atypical depression subtype. Its high stability over time and repeated identification in 
both younger and older cohorts makes it an increasingly well-defined subtype, facilitating 
research into treatment response. An observational study about atypical depression 
concludes that atypical depression seems to react well to mono-amine-oxidase inhibitors 
(MAOI) (Thase 2007), but results to date remain largely inconclusive. It would be very 
interesting to resume research on the treatment of atypical depression, since knowledge 
on the atypical depression subtype will have increased since then.
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Final conclusions
Late-life depression is a heterogeneous condition, consisting of different subtypes with 
distinct symptom profiles and characteristics. We identified an atypical subtype, which 
was highly stable over time and correlated with metabolic symptoms. The melancholic 
subtype was correlated with low cardiovascular disease, which was similar to the 
melancholic subtype we identified in another cohort, and characterized by the presence 
of psychomotor disturbances. In contrast to studies in younger adults, we did not find 
a correlation between depression subtypes and biological disturbances. We think this is 
caused by the pathophysiology of aging and the often additional increase of both cortisol 
measures and inflammation due to ageing processes or somatic comorbidity, regardless of 
any co-existing psychopathology. This means that new approaches are needed to better 
understand pathophysiology of late-life depression. Given the poor prognosis of late-life 
depression, it also means that it is important to treat pathophysiological aging such as the 
development of somatic comorbidity rigidly, since this probably plays a role in both the 
development and persistence of late-life depression. Furthermore, it is important to know 
that in the presence of psychomotor disturbances and especially psychotic features in 
late-life depression, ECT will likely relieve all depressive symptoms rapidly. 
Epilogue
The stories of the two patients described in the first chapter of this thesis, with their 
similar diagnosis of depression but vastly different symptoms, have sparked my interest 
in late-life depression and its diverse presentation. Their long-time suffering before 
sufficient treatment was found has convinced me of the necessity to improve treatment 
algorithms. During my clinical work I have treated older patients who did not recover as 
well as the two patients I have described here, which felt sad but not unexpected given 
the worse prognosis there is for depression in older adults. I have treated patients with 
an often very complex medical history, who sometimes suffered from a large amount of 
pharmacological side effects, and who have experienced a relapse into depression after a 
seemingly small stressor such as a cold or an argument with a loved one. Both my clinical 
work and my research have made me realize how incredibly complex late-life depression 
is. While my work with patients has motivated me to better understand the concept of 
depression, my research has taught me to increasingly regard the development and 
treatment of depression as complex and multifactorial, and how it might take multiple, 
and sometimes creative, solutions to try and restore my patients’ mental balance. I hope 
this thesis will contribute to a better understanding of late-life depression, and will inspire 
further research into this urgent, sometimes Gordian, but always intriguing subject.
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Depressie bij ouderen
Samenvatting
Depressie bij ouderen is een veelvoorkomende aandoening met een hoge ziektelast voor 
patiënten, hun naasten, en de maatschappij (Gallo et al. 2007; Unützer et al. 2009). Meer 
kennis over het gericht behandelen en de prognose voor individuele patiënten is daarom 
van groot belang. Depressie is echter een heterogeen begrip met vele verschillende 
uitingsvormen, wat onderzoek bemoeilijkt alsmede de diagnostiek en behandeling in 
de klinische praktijk. De Diagnostic and Statistical Manual of Mental Disorders versie 5 
(DSM-5) (American Psychiatric Association 2013) beschrijft verschillende subtypen van 
depressie, zoals atypische depressie welke gekenmerkt wordt door een toename van 
eetlust, gewicht en slaap. Een ander subtype dat wordt beschreven is de melancholische 
depressie, gekenmerkt door ondermeer een afname van eetlust, gewicht en slaap. Veel 
studies naar verschillen in pathofysiologie en behandeling hebben gebruik gemaakt 
van deze zogeheten DSM-gebaseerde klinische subtypen, maar de resultaten zijn tot op 
heden niet eenduidig. 
In dit proefschrift is gebruik gemaakt van andere methodes om potentiële subtypen van 
depressie bij ouderen in kaart te brengen. Met zogeheten data-gedreven technieken, 
waarbij de rekenkracht van de computer gebruikt wordt om hypothesevrij onderzoek te 
doen naar subtypen, hebben we geprobeerd om de heterogeniteit van depressie verder 
in kaart te brengen. Hierbij is specifiek gefocust op de melancholische depressie. Daarna 
hebben we gekeken naar verschillen in klinische presentatie en biologische parameters 
tussen de subtypen. Om de klinische relevantie van de melancholische depressie te kunnen 
bepalen hebben we nagegaan in hoeverre het melancholische subtype, gekenmerkt 
door (ernstige) psychomotore symptomen, de uitkomst van electroconvulsietherapie 
(ECT) voorspelt. Ook hebben we onderzocht of clusters van depressieve symptomen, 
geïdentificeerd door factoranalyse, een verschil toonden in responssnelheid. 
Subtypen van depressie en hun stabiliteit over de tijd
In hoofdstuk 2 hebben we een latente-klassenanalyse uitgevoerd bij een cohort van 359 
ouderen met een depressie. Hiervoor zijn data gebruikt van de Nederlandse Studie naar 
Depressie bij Ouderen (NESDO) (Comijs et al. 2011). In onze analyse werden drie groepen 
of subtypen geïdentificeerd: een matig ernstig subtype (prevalentie 46.5%), een ernstig 
melancholisch subtype (prevalentie 38.4%) en een ernstig atypisch subtype (prevalentie 
15.0%). De meest onderscheidende karakteristieken tussen de drie subtypen waren 
eetlust en gewicht, en in mindere mate psychomotore symptomen en verlies van interesse. 
Vergeleken met het melancholische subtype had het atypische subtype het hoogste 
percentage vrouwen, de laagste gemiddelde leeftijd, de hoogste Body Mass Index (BMI), 
en de hoogste prevalentie van zowel hart- en vaatziekten als metabool syndroom. 
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In hoofdstuk 3 hebben we onderzocht of de subtypen verschilden wat betreft 
biologische parameters. Resultaten van eerdere studies lieten zien dat depressieve 
subtypen verschillen in de hoogte van ontstekingswaarden en in het functioneren van 
de hypofyse-hypothalamus-bijnieras (hypothalamic-pituitary-adrenal (HPA) axis) (Gold 
en Chrousos 2002; Stetler en Miller 2012; Lamers et al. 2013; Penninx et al. 2013). Dit kan 
betekenen dat er verschillende pathofysiologische mechanismen aan deze subtypen ten 
grondslag liggen. In dit hoofdstuk onderzochten we verschillen in de ontstekingswaarden 
C-reactive proteïne (CRP), interleukine-6 (IL-6), neutrofiel-gelatinase-geassocieerd 
lipocaline (neutrophil gelatinase-associated lipocalin, NGAL), en in verschillende 
cortisolmetingen. Onze gevonden subtypen verschilden echter niet in de hoogte van 
de ontstekingsparameters en cortisolwaarden, ook niet na correctie voor mogelijke 
confounders.
Om de klinische relevantie van de gevonden subtypen verder te onderzoeken hebben we 
in hoofdstuk 4 de stabiliteit van de subtypen over een periode van twee jaar nagegaan. 
We hebben wederom data van de NESDO-studie gebruikt, maar dit keer zijn alleen 
personen geïncludeerd die op zowel meetmoment T0 (baseline) als meetmoment T1 (na 
twee jaar) voldeden aan de criteria van een depressie (N=111). Op T0 en T1 is een latente-
klassenanalyse uitgevoerd, en daarna een latente-transitieanalyse om de stabiliteit van 
de gevonden subtypen te meten over de tijd. Bij een latente-transitieanalyse wordt 
gekeken in hoeverre de subtypen vergelijkbaar zijn op T0 en T1, en hoe de onderlinge 
stabiliteit en verschuivingen van subtypen eruitzien. Wij vonden twee subtypen op zowel 
T0 als T1, namelijk een atypisch subtype (prevalentie 19.8% op T0 en 37.8% op T1) en een 
melancholisch subtype (prevalentie 80.2% op T0 en 62.2% op T1). Het atypische subtype 
had een stabiliteit van 0.93 en het melancholische subtype een stabiliteit van 0.86, wat 
wijst op een hoge stabiliteit over de tijd. Het matig-ernstige subtype dat werd gevonden 
in hoofdstuk 2 werd niet teruggevonden. 
Melancholische depressie en electroconvulsietherapie
In hoofdstuk 5 onderzochten we of melancholische kenmerken van depressies bij ouderen 
een voorspeller waren voor een positieve respons op ECT. Hierbij is melancholische 
depressie gekarakteriseerd als een depressie gekenmerkt door ernstige psychomotore 
symptomen, waarbij deze symptomen gemeten werden met de CORE-vragenlijst (Parker 
et al. 1995). Er was sprake van een melancholische depressie als iemand 8 punten of 
hoger scoorde. In deze studie zijn 110 patiënten geïncludeerd vanuit de Mood Disorders 
in Elderly Treated with ECT (MODECT) studie (Dols et al. 2017). We vergeleken kenmerken 
van melancholische en niet-melancholische patiënten, en onderzochten of de CORE-
score voorspellend was voor respons en remissie, en voor de tijd waarin dit behaald 
werd. We vonden dat patiënten met een melancholische depressie gemiddeld ernstiger 
depressief waren, slechter scoorden op cognitief en algemeen functioneren, en een lagere 
prevalentie hadden van hart- en vaatziekten. De relatie tussen melancholische depressie 
en hart-en vaatziekten werd ook gevonden in het data-gedreven melancholische subtype 
in hoofdstuk 2. Er werd echter geen relatie gevonden tussen CORE-score en remissie/ 
respons. Er was wel een significante relatie tussen remissie/ respons en psychotische 
symptomen, iets wat al eerder is gevonden (Van Diermen et al. 2018). In ons cohort was 
er sprake van een hoge prevalentie van psychotische symptomen (N=61). Dit kan ertoe 
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geleid hebben dat de CORE als voorspeller voor remissie/response niet meer significant 
was omdat deze door het effect van psychotische symptomen werd versluierd. We hebben 
daarom gekeken of de CORE wel een voorspellende waarde had in de groep mensen 
zonder psychotische symptomen (N=49). In deze groep was het remissiepercentage 62%, 
en de relatie tussen CORE-scores en remissie was bijna significant (p=0.057). 
In de laatste studie in hoofdstuk 6 hebben we nagegaan of ECT alle depressieve 
symptomen met dezelfde snelheid verbetert. Verschillen in responssnelheid zeggen 
mogelijk iets over het onderliggende werkingsmechanisme van ECT, en deze kennis kan 
helpen om de symptoomprofielen van depressie te identificeren die het meest zullen 
profiteren van ECT. In hoofdstuk 6 hebben we daarom gekeken naar de verbetering 
van depressieve symptomen in de eerste twee weken van ECT. Om zogeheten multiple 
comparisons te voorkomen hebben we een factoranalyse uitgevoerd, waarbij de tien 
depressieve symptomen samen zijn gevoegd tot enkele symptoomdimensies. Depressieve 
symptomen werden gemeten met de Montgomery-Asberg Depression Rating Scale 
(MADRS). Verschillen in de responssnelheid werden geanalyseerd met multilevel analyses. 
We vonden drie symptoomdimensies, te weten ‘stemming’, ‘melancholisch’, en ‘suïcidaal’. 
‘Stemming’ liet de grootste daling in ernst zien en verschilde na een week significant van 
de andere twee dimensies. Na twee weken waren zowel ‘stemming’ als ‘melancholisch’ 
significant gedaald ten opzichte van ‘suïcidaal’, maar alle symptoomdimensies lieten een 
snelle en grote daling zien van de ernst binnen twee weken. 
Tot slot wordt in het hoofdstuk ‘Summary, discussion and conclusions’ bediscussieerd 
hoe deze bevindingen te begrijpen zijn in het licht van de bestaande literatuur en welke 
klinische implicaties deze resultaten hebben. Ook wordt besproken welk vervolgonderzoek 
nodig is om het begrip over subtypen van depressie bij ouderen verder te verbeteren. 
Een belangrijke bevinding is de identificatie van de melancholische, atypische, en 
matig ernstige subtypen in hoofdstuk 2 en 3. Opvallend is dat deze subtypen een 
eigen symptoomprofiel en onderscheidende karakteristieken hebben, en relatief 
stabiel zijn in de tijd. We vonden echter geen biologische correlaten van de subtypen, 
in tegenstelling tot studies bij jongere volwassenen. Dit komt mogelijk doordat (patho)
fysiologische veroudering, bijkomende lichamelijke ziektes, en medicatiegebruik ook 
alle invloed hebben op ontstekingsparameters en cortisolwaarden, en zo de resultaten 
vertroebelen. Dit wordt waarschijnlijk verder versterkt door de toegenomen lichamelijke 
comorbiditeit en polyfarmacie bij depressie op oudere leeftijd, vergeleken met ouderen 
zonder depressie. Een beter begrip van depressie bij ouderen kan dan het beste bereikt 
worden door het complexe netwerk van fysiologische systemen te bestuderen. Deze 
benadering past ook bij de bevinding dat de prognose van depressie bij ouderen in het 
algemeen slechter is dan bij jongeren. Als in een complex systeem meerdere onderdelen 
uit evenwicht zijn is dit veel moeilijker te herstellen bij een kwetsbare oudere met weinig 
reservecapaciteit dan bij een veerkrachtige jongere volwassene. In de klinische praktijk 
moet dan ook altijd aandacht zijn voor de brede gezondheid van de oudere patiënt, zeker 
als de depressie moeilijk te behandelen blijkt. 
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In de hoofdstukken 5 en 6 werd gevonden dat psychotische verschijnselen een 
voorspeller zijn voor een goede respons op ECT, en dat in de groep niet-psychotische 
depressieve patiënten de CORE net geen significante voorspeller is voor respons. Deze 
bevindingen sluiten aan bij de hypothese van Parker et al. (2010) dat psychose de 
overtreffende trap van ernst is binnen de melancholische depressie. Ondanks dat vooral 
psychomotore symptomen gerelateerd zijn aan een beter resultaat van ECT, vonden 
we dat alle symptomen verbeteren met ECT. Dit is verder bewijs dat ECT een snelle en 
effectieve behandelmanier is voor ouderen met een ernstige, melancholische depressie, 
en een belangrijke plaats verdient in het behandelprotocol van depressie bij ouderen. 
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